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ABSTRACT 
Background: Embryonic stem (ES) cells are pluripotent and can differentiate into stem 
and progenitor cells of the three primary germ layers of the embryo~endoderm, 
mesoderm, and ectoderm. Stem cell technology could induce and differentiate ES cells 
into cells of interest in-vitro, but with different efficacies in terms of yield, purity, 
viability and functionality. The derived cell products can potentially serve as a novel 
regimen for survivors with permanent neurological deficits. 
Objectives: The induction of ES cells into neural cell lineage is currently facing the 
hurdles of low yield and impure population. A novel induction method is the 
prerequisite for providing a sufficiently pure neural cell population for cell replacement 
in neurodegenerative diseases. The applicability of the stromal cell-derived inducing 
activity (SDIA) of ancillary cells, mimicking the in-vivo micro-environment of the 
central nervous system (CNS), in the induction of ES cells into neural cell lineage was 
elucidated in-vitro and in-vivo. 
Materials & Methods: Mouse ES cell lines, D3 and E14TG2a were propagated in 
either serum-based or serum-free culture media with or without the support of either 
mouse primary embryonic fibroblasts (PMEF) or mouse fibroblast cell line STO on 
different plastic culture wares. The optimal condition was pursued for downstream 
‘ studies. The SDIA of mouse neural precursor CI7.2 cells, areola-derived L cells and 
Wnt-3A-secreting L-Wnt-3A cells in the induction of mouse ES cell lines, D3 and 
E14TG2a, were studied in vitro by non-contact co-cultures and conditioned medium 
iii 
(CM)-supplemented cultures. Stromal cells were analyzed for neurotrophic and neuro-
protective factors. ES cell-derived cell products were immunologically and molecularly 
characterized for neural cell markers and lineage commitment, respectively. In-vivo 
studies of the SDIA-induced cell products were conducted in the mouse model of brain 
ischaemia induced by transient bilateral common carotid artery occlusion (BCCAO) and 
reperfusion. Behavioural assessment of ischaemic mice after intracranial implantation 
of ES cell-derived cell product onto the striatum was performed in the water maze 
system to evaluate spatial learning and memory ability. The tracking of bromo-
deoxyuridine (BrdU) labelled ES cell-derived cell products was made on brain sections 
of transplanted mice and teratoma formation was also examined. 
Results: ES cells were best maintained and passaged in-vitro on PMEF in culture 
medium supplemented with defined serum as revealed by the preponderance of the 
stage-specific embryonic antigen-1 (SSEA-1). 
Brain derived neurotrophic factor (BDNF), glial cell line derived neurotrophic factor 
(GDNF), ciliary neurotrophic factor (CNTF), nerve growth factor (NGF), neurotrophin-
3 (NT-3), insulin-like growth factors-1 and 2 (IGF-1 and -2), basic fibroblast growth 
factor (bFGF), vascular endothelial growth factor (VEGF) and erythropoietin (EPO) 
were detected in CI7.2 cells, L cells and L-Wnt-3A cells suggesting the neurotrophic 
and neuro-protective potential. The immuno-reactivity of neuroepithelial stem cell 
intermediate filament (nestin), beta-tubulin class III (TuJ III), micro tubule-associated 
protein-2 (MAP-2), tyrosine hydroxylase (TH), glial fibrillary acidic protein (GFAP), 
iv 
and myelin binding protein (MBP) in the ES cell-derived cell products suggested the 
growth of a cell population in hierarchy of the neural cell lineage. The expression of 
neural cell lineage-related genes, Pax6, Otxl and Nurrl, indicated neuroectodermal 
precursors, in addition to neural stem cells, mature neurons, dopaminergic (DA) neurons, 
astrocytes and oligodendrocytes, in ES cell-derived cell products. The products were 
likely free from mesodermal and endodennal cells as no gene products of Brachyury and 
a-fetoprotein (AFP) were amplified, respectively. Nevertheless, weak expression of the 
transcription factor Oct-4 was noted. The SDIA was remarkable in both co-cultures and 
CM-supplemented cultures, despite the readouts derived from half-diluted CM was a bit 
lesser. A proportion of 75% nestin+ colonies were achieved in the co-cultures of D3 and 
C17.2. 
In-vivo studies of the SDIA-induced cell products displayed a significant improvement 
in spatial learning and memory ability in ischaemic mice post-transplant as compared to 
ischaemic mice receiving sham operation. Localization of BrdU-labelled cells along the 
needle track of injection in the brain was evident. There was migration of BrdU+ cells in 
the vicinity and few BrdU+ cells were examined in brain tissues contra-lateral to the site 
of injection. Nevertheless, teratoma developed in a mouse. 
Conclusion: A hierarchical population of neural cell lineage could be in-vitro derived 
from ES cells through the SDIA of neural precursor cell line CI7.2. The clinical 
.1 
relevance was evident in a mouse model of brain ischaemia. However, there is still 
XV 
room for improvement to prevent the formation of post-transplant teratoma. The finding 
of this study may help translating to human setting. 
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作用。 •  ‘ 
材料和方法：採用了有/無血清培養基，有/無鼠原代胚胎成纖維細胞或鼠成纖維細 
胞系S T O滋養以及不同材料的塑膠皿等方法來培養鼠胚胎幹細胞系D 3和 
E14TG2a，並尋找最佳的適應環境。我們分別用不接觸共同培養法和條件培養基 









方法檢測到C17.2細胞’ L細胞’和L-Wnt-3A細胞有SDA^F, GDNF’ CNTF, NGF, 
NT-3, IGF-1, IGF-2, bFGF, VEGF和Ei^O的存在’說明這些細胞有神經營養和神 
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Chapter 1 Introduction 
1.1 Embryonic stem (ES) cells 
ES cells originate from the blastocyst stage of the embryo prior to implantation 
onto the uterine wall. In mouse, the pre-implantation embryo is made up of a 
constellation of cells with an outer layer of trophectoderm enclosing a fluid-filled cavity 
of blastocoel and a cluster of cells known as the inner cell mass (ICM). ES cells are 
derived from the ICM (Evans et al. 1981; Martin 1981). They lack the G1 checkpoint 
and are almost in the S phase of the cell cycle, during which they synthesize 
deoxyribonucleic acid (DNA). Unlike differentiated somatic cells, ES cells do not 
require any external stimulus to initiate DNA replication. They express the transcription 
factor, Octamer-binding transcription factor-4 {Oct-4\ (Okamoto et al. 1990) and are 
capable of undergoing an unlimited number of symmetrical divisions without 
„ differentiating to give rise to a colony of identical cells or clones that have the same 
properties as the original cell. Proliferating ES cells maintain stable normal diploid 
karyotypes (Odorico et al. 2001). However they show no sign of X-chromosome 
inactivation, which takes place normally in all female somatic cells that one of the two 
X-chromosomes becomes permanently inactivated (Marshak 2001; Smith 2001). 
J ES cells are pluripotent and can differentiate into stem and progenitor cells of the 
three primary germ layers of the embryo一endoderm, mesoderm, and ectoderm (Wiles 
1993; Smith 2001). ES cells are also capable of colonizing the germ line and giving rise 
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to egg or sperm cells (Hubner et al. 2003; Geijsen et al. 2004). By injecting ES cells 
into the cavity of another blastocyst and transferring the engineered embryos into the 
uterus of a pseudo-pregnant female mouse, chimeras were formed resulting to progenies 
derived from both donor ES cells and the recipient blastocyst (Beddington et al. 1989). 
When ES cells were implanted under the skin or into the kidney capsule of adult nude 
mice, tumors in the form of teratoma, which is characteristic of the outgrowth of cells of 
the three dermal layers (Ringden et al. 2003). As ES cells are cultured in-vitro, they can 
differentiate spontaneously by forming embryoid bodies (EB; Martin et al. 1975; 
Itskovitz-Eldor et al. 2000; Toumadje et al. 2003; Heo et al. 2005), which resemble 
teratomas in-yivo. EB resemble early post implantation embryos and consist of a 
disorganized array of differentiated or partially differentiated cell types of three primary 
germ layers of the embryo (Reubinoff et al. 2000; Odorico et al. 2001; Gepstein 2002). 
Mouse ES cells were isolated for the first time in mice in 1981 (Evans and 
Kaufman 1981; Martin 1981). It was a major breakthrough in the field of developmental 
biology. ES cells were allowed to grow indefinitely in an undifferentiated state, without 
senescence, in the presence of leukemia inhibitory factor (LIF; Williams et al. 1988) and 
mitotically inactivated primary mouse embryonic fibroblasts (PMEF) or STO mouse 
fibroblasts (Martin and Evans 1975). Murine ES cell lines are proven to be able to 
differentiate in-vitro into a variety of embryonic and adult cell types of three embryonic 
germ layers (Table 1). Thereafter many ES cell lines are available from cattle (Chemy 
et al. 1994), pig (Gerfen RW et al. 1995), primates (Thomson et al. 1995). In 1998, 
Thomson and his group at the University of Wisconsin-Madison successfully established 
2. 
ES cell line from human early embryos (Thomson et al. 1998). To date, approximately 
30 human ES cell lines are developed (Gearhart 2004). 
J * 
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Table 1 ES cell derivation 
Germ Layer Cell types References 
Endoderm Pancreatic Islets (Lumelsky et al. 2001) 
Adipocyte (Dani et al. 1997) 
Mesoderm Hematopoietic cells (Wiles et al. 1991) 
Cardiomyocyte (Doetschman et al. 1985) 
(Maltsev et al. 1993) 
Ectoderm ，Neuron (Bain et al. 1995) 
Keratinocyte (Strubing et al. 1995) 
(Bagutti et al. 1996) 
4. 
1.2 Stem cell plasticity 
Apart from ES cells, there are many types of stem cells namely, haematopoietic 
stem cells (HSC), neural stem cells (NSC), skin stem cells, mesenchymal stem cells 
(MSG), pancreatic progenitor and many other site-specific stem cells. They are 
essentially undifferentiated cells that can be found in the developing embryo, foetus and 
adult body. All have the capacities of self-renewal and differentiation (O'Shea 2004) to 
replenish cell loss in a homeostatic manner throughout life (Lindblad 2001). In optimal 
in-vitro culture conditions, they can be trans-differentiated into cells of different lineages 
(Burke et al. 2005). ” 
1.2.1 Differentiation and trans-differentiation of lineage-restricted stem cells 
1.2.1.1 Multilineage differentiation in-vitro 
‘ Recent publications demonstrated that ES cells could be induced to form the 
desired cell phenotype in-vitro when appropriate culture conditions were provided 
(Maltsev et al. 1993; Hole 1999; Rosenberger 2003; Schulz et al. 2004). These included 
cardiomyocytes, hematopoitic cells, neural cells, myocytes, adipocytes, hepatocytes, 
epithelial cells, liver cells and many others. It was also shown that ES cells could also 
give rise multipotent lineage-restricted stem cells such as HSC, NSC, liver stem cells 
,1 
and etc (Hole 1999; Chen et al. 2003; Bibel et al. 2004). 
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1.2.1.2 Trans-differentiation 
Under suitable conditions, multipotent tissue-specific stem cells are capable of 
producing a whole spectrum of cell types, regardless whether progenies are derived from 
the same germ layer (Passier et al. 2003). HSC could be converted into many other 
types of cell under suitable condition, including liver and neural cells (Hao et al. 2003). 
NSC could be converted into hematopoietic cells (Shih et al. 2002), and skeletal 
muscular cells (Vescovi et al. 2002). Bone marrow stromal cells could be turned into a 
variety of non-haematopoietic cells of ectodermal, mesodermal and endodermal origins 
such as myocytes, neural cells and hepatocytes (Tao et al. 2003). 
Trans-differentiation is interesting as it raises the possibility of obtaining 
autologous lineage-restricted healthy stem cells and converting them into cells of interest 
for tissue repairs without difficulties in collecting lineage-specific stem cells from 
allogeneic donor. It is now premature to argue that adult somatic stem cells should be 
pursued in preference to ES cells. In facts, these two areas of research are 
complementary and synergistic. 
6. 
1.2.2 Prospective applications of stem cells 
1.2.2.1 Basic research on development 
ES cells are undoubtedly used as a key research tool for understanding molecular 
machinery, growth factors, cytokines, chemokines, adhesion molecules, ligands and 
other yet unknown substances during the process of differentiation from the embryonic 
stage to the adult phenotype. They may help elucidating the causes of birth defects so 
that prospective measures can be implemented for disease correction and prevention 
(Evans 1989;卫athjen et al. 1998). Besides, chromosomal abnormalities in early 
development can also be explored with ES cells in which the developments of early 
childhood malignancies are embryonic in origin. 
1.2.2.2 Study of human disease 
• ES cells provide a good model for the study of human-only diseases including 
acquired immuno-deficiency syndrome and hepatitis C, which are severely constrained 
by a lack of in-vitro models. 
1.2.2.3 Cancer research 
；/ 
ES cells can nourish an unlimited supply of lineage-specific stem cells catering 
for the physiological need. There is a plethora of evidence suggesting the attributes of 
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cancer stem cells in human malignancy. ES cells can be a good vehicle for delivering 
genes to specific tissues in the body and restoration of the immune function to tackle 
cancer. Currently many ways have been devised to utilize specialized cells derived from 
ES cells to target specific cancerous cells. 
1.2.2.4 Drug screening 
Despite in-vivo testing in animals is a mainstay of pharmaceutical research, the 
efficacy in human can hardly be foreseen. Human ES cells can derive a stable and pure 
population of cells of interest for drug testing in a real, live and fairly normal manner 
prior to clinical trials (McNeish 2004). 
1.2.2.5 Cell therapy 
Degenerative disorders like myocardial infarction, Parkinson's disease, diabetes 
aie attributable to the progressive, either acute or chronic, loss of functional cells in 
disease, injury and/or aging. The replacement of the worn-out or injured cells by quality 
cells to restore the normal physiological functions of tissues or organs is the underlying 
principle of regenerative medicine (Rathjen et al. 1998; Fodor 2003; Doss et al. 2004). 
Despite recent advances in transplantation medicine, there is a shortage of donor 
organs. However, ES cells could potentially revolutionize medicine by providing an 
unlimited and renewable supply of cells capable of replacing or repairing tissues that 
8. 
have been damaged in degenerative disorders or diseases leading to the deprivation of 
functional cells. ES cell-based replacement therapy was reported to be efficient 
(Rohwedel et al. 1994; Delcarpio et al. 1995; Barberi et al. 2003). 
1.3 Neuro-degenerative diseases and cell therapy 
1.3.1 Neuro-degenerative diseases 
There are mainly two types of cells: neurons and glial cells in the brain. Neurons 
transmit electric signals, controlling all actions of body parts. Glial cells are categorized 
in oligodendroglia and astroglia. Oligodendrocytes are responsible for producing myelin, 
a fatty substance that provides electrical insulation on the axons. Death of 
oligodendrocytes results in demyelination, halting communication between the brain and 
the rest of the body. Astrocytes break down and remove harmful proteins, as well as 
secrete proteins called neurotrophic factors, which help neurons survive and grow. They 
also respond to injury. They clear away debris, which results in formation of glial 
scarring (Siegel 1999). 
Both neurons and glial cells are important. Disorder in one of them in 
neurodegenerative disease would probably cause dysfunction of brain, and seriously 
affects the daily life of patients. Moreover, there is usually no effective therapy for 
neurodegenerative disease. 
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With the establishment of ES cells and their two characteristics, it provides a big 
hope for supplying unlimited source, by simply inducing their differentiation into certain 
cells of interests, to replace the cells loss and dysfunction cells in neurodegenerative 
diseases, include the stroke (Famularo et al. 1998; Nadareishvili et al. 1999)，spinal cord 
injury (Baleriaux 1991), Parkinson's disease (Hirsch et al. 1988; Siegel 1999), 
Alzheimer disease (Arenas 2002), multiple sclerosis (Foote et al. 2005). 
1.3.2 Neuro-regeneration 
Over the past decades, convincing evidence suggested that neurogenesis in the 
adult CNS is a continuous physiological process. The production of new neurons is 
noted in the sub-ventricular zone and the sub-granular zone of the dentate gyrus (Galli et 
al. 2003). It was demonstrated in animal models of disease of or injury to CNS, such as 
seizures and traumatic brain injury, neurogenesis would be induced. Global forebrain 
ischaemia and focal ischaemia in adult mammals were noted to enhance neurogenesis in 
the dentate gyrus (Nakatomi et al. 2002; Hallbergson et al. 2003; Briones et al. 2005). 
Besides, it was reported that newly formed neurons can replace degenerated neurons at 
the lesioned site and improve the neural function. However, the mortality of the new 
neurons is high and over 80% died within the first six weeks. Approximately 0.2% of 
the injured cells could be replaced by newly generated neurons (Arvidsson et al. 2002). 
Besides, it was reported that neural stem cells in brain constitutively secrete 
neurotrophic factors, neural inducing factors, survival promoting factors that promote 
extensive neuronal growth after injury (Lu et al. 2003; Serpe et al. 2005). 
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1.3.3 Cell sources for neuro-regenerative therapy 
1.3.3.1 Comparison of stem cells 
There are mainly two categories of stem cells: embryonic and adult stem cells. 
Recently, NSC, HSC and MSC are the adult stem cells that widely used in 
differentiation research (NIH 2001). Table 2 shows the comparison of ES cells and 
various adult somatic stem cells. 
In fact, embryonic and adult stem cells vary significantly in terms of potential 
use in cell-based therapies. They show differences in the number and type of 
differentiated cells which they can derive. ES cells are pluripotent that become all cell 
types of the body. Adult stem cells, especially NSC are generally limited to 
differentiating into different cell types of their tissue of origin. This may be an 
advantage to yield a relatively homogeneous cell population having a high purity, while 
„ ES cells usually yield heterogeneous cell products with a low purity. 
ES cells in large numbers can proliferate indefinitely in culture, while adult 
stem cells are rare in mature tissues and could only grow in cultures for a shorter time 
than that of ES cells. Adult stem cells are not easily harvested from living people, 
especially the NSC. There is little adult stem cell line established at the moment. That 
丨I is the reason why many works were done on ES cells than adult stem cells. 
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A potential advantage of using adult stem cells is that the risk of immune 
response is highly reduced as the graft is originated from the same patients. This is a 
significant advantage as immune rejection is a difficult problem that can only be 
circumvented with immunosuppressive drugs. On the other hand, immune response to 
ES cells may be elicited although it has not been determined in human experiments 
(Drukker et al. 2004; Li et al. 2004). Moreover, application of ES cells in cellular 
therapy poses the risk of teratomas formation (Reubinoff et al. 2000; Amhold et al. 
2004). 
1.3.3.2 Stem cells in neuro-regenerative therapy 
The main rationale of cellular therapies for neuro-regeneration is to replace 
degenerated or lost neurons and glial cells in the affected region, to re-establish and to 
maintain the functional neuronal circuitry in the brain (Dinsmore 1998). Furthermore, 
cell-based approaches could also exert neurotrophic efforts to tissue surrounding the 
injured area and help promote survival, migration and differentiation of endogenous 
stem and precursor cells by secreting survival promoting factors, migratory factors or 
neural inducing factors (Alzheimer et al. 2002; Lazarini et al. 2003; Yoshimura et al. 
2003; Tran et al. 2004; Cheng et al. 2005). 
Cellular therapy employing large numbers of ex-vivo derived viable neural cells 
•I 
may hold promise to patients with neuro-degenerative disease by replenishing the loss of 
functional neural cells. A reliable and accessible cell source is requisite. There are 
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many potential sources of stem cells which can be utilized to pursue the goal (Passier 
and Mummery 2003). Among them, ES cells and adult somatic stem cells derived from 
the CNS and haematopoietic system are very attractive for neuro-regeneration. 
Transplantation of human NSC as allograft is currently one of the feasible way 
used to treat Parkinson's disease. However, the source of adult and foetal NSC is rare 
and limited. It was reported that the number of foetal NSC isolated from six to ten 
aborted foetuses could only cater for transplantation of a patient with Parkinson's 
disease (Hynes et al. 2000). Besides, the human NSC are not easily harvestable for 
transplantation unless collected during necropsy (Kuhn et al. 2001; Sanai et al. 2004). 
The isolated adult or foetal NSC are difficult to maintain in-vitro. They could be 
passaged merely a few times. The technical hurdle in the ex-vivo expansion of NSC has 
restricted the generation of sufficient numbers of specialized cells for transplantation. 
Therefore, the accessibility of collection of HSC from bone marrow, umbilical 
cord blood and peripheral blood is advantageous over the harvest of NSC. Trans-
differentiation of HSC into neural lineage was reported (Haas et al. 2005) and many pre-
clinical studies were conducted in animal models to investigate the regenerative capacity 
of HSC following brain damage of ischaemic stroke (Hao et al. 2003), by either 
mobilization of intrinsic HSC pools or transplantation of exogenous HSC. It was 
interesting to note a three-fold increase of circulating HSC, in terms of CD34+ cell count, 
‘I 
in patients with acute cerebral ischaemia (Peterson 2004; Ladeby et al. 2005). A recent 
pre-clinical study reported functional improvement in rats with focal cerebral ischaemia 
* 
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after subcutaneous administration of granulocyte colony stimulating factor (G-CSF), 
suggesting the neuro-protective effect of G-CSF-mobilized HSC (Shyu et al. 2004). In 
animal studies, the intravenous administration of human umbilical cord blood-derived 
CD34+ cells to mice and rats promoted neo-vascularization and neurogenesis with 
concomitant functional improvement (Taguchi et al. 2004). 
Preliminary implantation studies in animal models showed that ES cell-derived 
cell products were functionally active, and integrated into the brain and corrected the 
phenotype of neuro-degenerative disease (Takagi et al. 2005; Xu et al. 2005). It was 
noted that the immunogenicity of neural tissue was relatively low as compared with 
other tissues. This makes ES cell-based cell replacement therapy for neuro-degenerative 
disease and neurological disorders less likely of immune-rejection. 
Compared with ES cells, adult somatic stem cells would raise less ethical 
concerns (Ringden et al. 2003). However, adult somatic stem cells are not as good as ES 
ceils in term of differentiation potential. Embryonic carcinoma (EC) cells and 
embryonic germ (EG) cells may be an alternative (Shamblott et al. 1998; Laslett et al. 
2003; Przyborski et al. 2004). EG cells are derived from primordial germ-line cells in 
gonadal ridge at five to nine weeks of development, whereas EC cells originated from 
teratocarcinoma, usually a tumour of testis. Unlike ES cells, studies EC or EG cells in 
animals are limited. 
14. 
The purity of ES cell-derived neural cultures has been problematic. Besides, the 
implantation to human brain is hindered by the fear of spontaneous formation of 
teratoma. However, ES cells display many advantages over adult somatic stem cells. 
They have relatively high differentiation capacity and can readily differentiate into cells 
of all three germ layers. On the contrary, adult somatic stem cells commit to cells of 
specific lineage. To date, with the exception of HSC, which display the ability of trans-
differentiation, there is no data suggesting that adult somatic stem cells could herald 














































































































































































































































































1.4 In-vitro derivation into neural lineage 
With the withdrawal of LIF, and/or removal from the feeder support and 
subsequent transferral to a suspension culture, ES cells differentiate spontaneously into 
multicellular aggregates - EB. With optimized in-vitro culture conditions, a high yield 
of quality neural lineage cells can be derived (O'Shea 2001; Xian et al. 2001). 
1.4.1 In-vitro induction strategies available 
Basically, ES cells resemble early post-implantation embryos (Brook et al. 1997). 
Cell-cell interactions are critical to normal embryonic development. Simulating these 
native in-vivo interactions in in-vitro cultures is a fundamental strategy of ES cell 
induction. The in-vivo conditions can be mimicked by adding chemical stimulants 
and/or growth factors into the culture medium. A variety of coating matrices are used to 
enhance adherence to culture wares for better cell growth (Ekblom et al. 1986). Besides, 
chemically modified culture wares are exploited to promote non-adherent cell 
aggregates in cultures. 
Many protocols were reported to be able to differentiate mouse ES cells into 
neural cell lineage cells of neurons, astroglia and oligodendroglia. However, the 
induction efficacy differs in terms of yield, purity, viability and functionality of cells of 
interest, not to mention the complexity of procedures and processing time required. 
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1.4.1.1 Chemical agents 
1.4.1.1.1 Retinoic acid (RA) 
RA is a well known inducing agent to enhance the differentiation of ES cells into 
specific mature phenotypes. RA is a biologically active form of vitamin A and has been 
shown to play an important role during embryogenesis (Ross et al. 2000). It is thought 
to be one of the most important extrinsic inductive agents for neural differentiation in 
vitro. It influences neural development in the early stage of CNS development. In 1982, 
Jones and co-workers induced PI9 teratocarcinoma cell line into neurons and glial cells 
using RA (Jones-Villeneuve et al. 1982). 
P19 cells and ES cells share a number of basic features. Both of them are 
pluripotent and can differentiate. Bain and co-workers applied a supraphysiological 
dose of RA to mouse ES cells via EB formation and obtained a high proportion of cells 
expressing multiple neuronal features (Bain et al. 1995; Fraichard et al. 1995; Strubing 
et al. 1995; Bain et al. 1996). About 38% of the ES cell-derived product illustrated the 
neuron-like morphology. They displayed neuronal markers of TuJ-III, neurofilament-M, 
gamma-aminobutyric acid-synthesizing enzyme and TH. The RA-induced neuron-like 
cells also demonstrated the electrophysiological property. 
However RA is a strong teratogen and is supposed to perturb neural patterning, 
there are concerns in using RA at concentrations far beyond the physiological range 
18. 
(Soprano et al. 1995; Sucov et al. 1995; Okada et al. 2004). Besides, it was reported that 
the absence of RA from the culture medium is required for successful induction of DA 
neurons (Wilson et al. 2004; Afonso et al. 2005). 
1.4.1.1.2 Ascorbic acid 
Ascorbic acid is a derivative of vitamin C. It has been successfully showed that 
ascorbic acid could enrich ES cell-derived TH+ neurons, together with Sonic Hedgehog 
(SHH), fibroblast growth factor-8 (FGF-8; Ye et al. 1998; Lee et al. 2000; Briscoe et al. 
2001). .. " 
1.4.1.2 Growth factors/cytokines 
In-vitro uses of cocktails of growth factors and cytokines, including 
neurotrophins, stimulants and even CM, to mimic the in-vivo microenvironment, had 
been reported to induce ES cells into neural lineage (Schulz et al. 2003). The relative 
concentrations were empirically and hypothetically determined according to their 
differential expressions during normal neurogenesis and brain injury. To-date, a number 
of neurotrophins or stimulants had been identified to be effective in promotion of neural 
differentiation (Alzheimer and Werner 2002; Hallbergson et al. 2003; Yoshimura et al. 
2003; Bondy et al. 2004; Schanzer et al. 2004; Shyu et al. 2004). 
ii 
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As neurogenesis is a very complex process involving many growth factors and 
cytokines, the supplement of a small cytokine cocktail may not provide an optimal 
induction condition for ES cells into neural lineage. Further tests on various 
combinations of factors would be necessary to promote the induction efficacy. 
1.4.1.2.1 Neurotrophins 
According to Park and co-workers, BDNF and transforming growth factor 
(TGF)-a could induce a higher number of DA neurons from ES cells. Moreover, GDNF 
can significantly enhance the differentiation and viability of ES cell-derived DA neurons 
(Guan et al. 2001; Rolletschek et al. 2001; Park et al. 2004). Barberi and coworkers also 
demonstrated CNTF could induce astrocytes generation after 18-day serum free 
condition (Johe et al. 1996; Barberi et al. 2003). NGF was also found to be a potent 
enhancer of neuronal differentiation, by eliciting extensive outgrowth of processes and 
expression of neural markers (Schuldiner et al. 2001). NT-3 and NT-4 are the members 
of NGF family. They increase the number of neurons by increasing neuronal survival, 
but rather than inducing neuronal phenotype (Johe et al. 1996; Caldwell et al. 2001). 
1.4.1.2.2 Stimulants 
Basic FGF and EGF are reported to involve in enrichment and expansion of 
.1 
proliferating neural progenitors from ES cells (Reubinoff et al. 2001; Park et al. 2004). 
VEGF is an angiogenic factor that appeared to play a significant role in the growth and 
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differentiation of astrocytes in the CNS. Moreover, its up-regulation will induce 
expression of bFGF. Thus, it suggested that VEGF may indirectly serve in the 
proliferation of multi-potential neural stem/progenitor cells both in in-vitro and in-vivo 
(Schanzer et al. 2004). 
Recently, it was shown that there was a cross-talk of hematopoietic factors to 
neural differentiation. It was suggested that SCF might play a role in cell migration and 
survival in the developing cortex (Erlandsson et al. 2004). Flt-3 ligand (FL) is a cytokine 
that promotes the survival, proliferation, and differentiation of hematopoietic progenitors. 
FL and its ligand have also been identified in brain tumors (Timeus et al. 2001). This 
further suggests that neuroectodermal and hematopoietic cells share common regulatory 
pathways. The effects of Erythropoietin (EPO) in glial cell development, especially 
oligodendrocytes maturation and astrocytes proliferation, were reported by a Japan 
group (Sugawa et al. 2002). With the treatment of EPO on glial cells, the proliferation of 
astrocytes and oligodendrocytes were enhanced. 
1.4.1.2.3 Signalling molecules 
It was reported that ES cells expressed SHH and the corresponding receptors 
during differentiation. The supplement of SHH to cultures resulted in a significant 
increase of TH+ neurons (Lee et al. 2000). Lee and co-workers induced ES cells to form 
EB in suspension and then stepwise into neural lineage. Similar observation was also 
noted by Ying and co-workers (Ying et al. 2003). 
21. 
It was hypothesized that neural fate of ES cells can be acquired through a default 
mechanism in which inductive signals for alternative fates are eliminated (Tropepe et al. 
2001). Bone morphogenetic protein (BMP) is a member of TGF-p superfamily of 
molecules that strongly inhibit neural differentiation. The binding of signaling molecules, 
Noggin and Chordin, could promote neural fate specification (Hemmati-Brivanlou et al. 
1994). 
Wnt signalling has been implicated in the expansion of neural precursor cells in 
the embryo. Wnt-1 and-Wnt-SA of Wnt-protein family cause expansion of neural 
precursor cells in the developing brain and spinal cord (Derfoul et al. 2004; Muroyama 
et al. 2004). They are required for the formation of several regions of the CNS, including 
the midbrain, diencephalon, hippocampus, and dorsal hindbrain (Shibamoto et al. 1998). 
The clinical relevance of chemical agents, growth factors, cytokines, stimulants 
and signaling molecules, either in unity or in combination, in the induction of ES cells 
into neural cell lineage is still not fully characterized and studied. 
J 
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1.4.1.3 Culture Selection 
1.4.1.3.1 Conditions 
Neurons or neural cells are very vulnerable to the culture conditions in vitro. 
Temperature, oxygen/carbon dioxide concentrations have to be carefully maintained for 
normal growth. Oxygen is toxic to neurons. Anti-oxidants, such as vitamin E, 
glutathione, pyruvate, catalase and superoxide dismutase, are found to increase survival 
and growth of neurons. Neuronal survival cultured in 9% oxygen for three days were 
more than double those in atmospheric oxygen (Brewer et al. 1989). At 0.2% carbon 
dioxide, neurons would die within hours due to the rapid rise in pH in culture medium 
(Brewer et al. 1996). Buffered culture medium should be used to avoid the pH changes 
during the course of experiment. 
1.4.1.3.2 Medium 
Culture medium plays an important role in neural differentiation. They may help 
expand and select the neural lineage cells. Basically, there are either serum-based or 
serum-free media. 
Foetal calf serum is an effective supplement for in-vitro cell culture because of 
its complexity and the multiplicity of growth-promoting, cell protection and nutritional 
factors. However, the favourable effects of serum derived from different batches/lots 
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vary considerably, not to mention various manufacturers using miscellaneous collecting 
and producing protocols. Certain factors may be deficient in some batches/lots or 
present in an excessive levels inhibitory to ES cell growth. It was reported serum 
inhibits neural differentiation (Pachemik et al. 2005). The applicability of foetal calf sera 
in ES cell maintenance had to be evaluated. 
Serum-free medium emerges as an alternative. Data of recent studies showed 
reported that N2- and B27-supplemented serum-free media support neural cell growth, 
but not other lineages (Romijn 1988; Brewer 1995; O'Shea 2001). 
Furthermore, adhesion molecule like fibronectin has been supplemented to 
culture medium (Okabe et al. 1996; Lee et al. 2000). It was reported that fibronectin 
increases the neural differentiation of ES cells by facilitating the growth of NSC as a 
monolayer without impairing their differentiation potential and generation of specific 
differentiated progeny for cell transplantation (Rappa et al. 2004). 
1.4.1.4 Transfection of regulator genes using viral vector 
Several transcription factors have been demonstrated to regulate differentiation 
of ES cells into specific cell types. By forced expression of such factors, ES cells are 
deliberately driven into a specific lineage. ES cells are genetically knocked-in an 
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antibiotic-resistant gene juxta-positioned to the promoter of a neural transcription factor 
using a viral vector. During the early stage of differentiation, the expression of 
antibiotic-resistant gene maintains cell growth of neural lineage in cultures 
supplemented with the particular antibiotic. Alternatively, the antibiotic blocks the 
endogenous translation or transcription machineries if alternative progenies do not 
express the particular enzyme or protein to antagonize the blocking activity. However, 
immuno-rej ection pertaining to the extraneous proteins expressed by the genetically 
engineered progenies may be a concern in the transplantation setting. 
Kim and co-workers demonstrated Nurrl over-expression in ES cells to induce 
dopaminergic differentiation in-vitro (Chung et al. 2002). Nurrl is a transcription factor 
critical for the development of midbrain dopaminergic (DA) neurons. The group showed 
that Nurrl-induced ES cells expressed DA neuronal markers, such as dopamine 
transporter, in addition to tyrosine hydroxylase, and gave a four to five-fold increase in 
the proportion of DA.. neurons after differentiation. Nurrl-induced ES cells also 
exhibited depolarization-evoked DA release. 
Besides Nurrl, neuroDs (O'Shea 1997) and Sox2 (Li et al. 1998) had also be 
manipulated to be over-expressed during induction of neural differentiation, and yield 
neural precursors and neural cells. These studies will serve as a framework of genetic 
engineering of ES cells by key transcription factor to regulate their cell fate. 
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1.4.1.5 Stromal cell-derived inducing activity (SDIA) 
There are many ancillary cells in the CNS and peripheral nervous system, apart 
from neurons. They act like feeders to support cell or tissue repair and may even 
account for other yet unidentified roles in neuro-regeneration. 
Kawasaki and co-workers screened various primary cell cultures and cell lines 
for activities promoting neural differentiation of ES cells in a serum-free co-culture 
system (Kawasaki et al. 2000). PA6 stromal cell line derived from skull bone marrow 
was noted to exert SDIA" and induce efficiently neuronal differentiation of ES cells in 
serum-free conditions without the use of either retinoic acid or EB induction. Stromal 
cell line 0P9 derived from mouse calvaria and the embryonic fibroblast line NIH3T3 
were also noted to elicit SDIA but to lower extent (Kawasaki et al. 2000; Vieira et al. 
2004). The SDIA-induced dopamine-positive neurons were functionally active in vitro 
and demonstrated electrophysiological property. In the in-vivo study, the DA neurons 
could integrate into the striatum of Parkinsonian mice and remained positive for tyrosine 
hydroxylase expression (Xu et al. 2005). No teratomas formed in the grafted tissue. 
Two likely mechanisms were hypothesized to the molecular nature of SDIA. 
SDIA may mediate neural factors which are either cell surface-anchored factors or labile 
soluble factors. Alternatively, secreted factors, which are secondarily tethered to the cell 
.1 
surface as exemplified by Wnt and FGF, may be attributed to SDIA. To date, it is still 
cannot identified all the important uncharacterized substances, including the secretory or 
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surface-anchored neural factors, and the labile soluble factors. Studies are mainly 
focusing on screening or selecting stromal cells to exert effective inducing activity on 
neural differentiation. Nevertheless, SDIA-induced cell product needs more studies to 




Chapter 2 Aims 
2.1 Hypothesis and study objectives 
Among the different protocols currently available to the induction of ES cells 
into neural lineage, SDIA should be a more physiologically relevant approach. The 
lineage-restricted neural progenitor cell line CI7.2，which was established from neonatal 
cerebellum of mouse (Snyder et al. 1992)，would best mimic the micro-environment of 
the CNS and help induce ES cells into neural lineage through SDIA (Lu et al. 2003). 
The objectives of this study are: 1) to evaluate the efficacy of neural precursor 
cell line C17.2 in the induction of ES cells into neural lineage by SDIA and compare the 
readouts to those derived from L cells, L-Wnt-3A cells and the teratogen RA, and 2) to 
assess the clinical relevance of the SDIA-mediated cell products in the mouse model of 
_ ischaemic brain. 
2.1.1 Soliciting an optimal method for ES cell propagation 
In-vitro culture conditions of ES cells were elucidated and optimized with 
respect to 1) different lots and batches of sera available from various suppliers, 2) 
i serum-based versus serum-free culture media, and 3) adherent cultures with and without 
feeder cell support. 
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2.1.2 Pursuing alternative SDIA 
That neural progenitor cell line C17.2 originated from the cerebellum was 
hypothesized to carry cues of the microenvironment of mouse brain, which may mediate 
SDIA of mouse ES cells into neural cell lineage. The neural progenitor cell line together 
with two stromal cell lines, L and L-Wnt-3A, were molecularly analyzed for 
neurotrophic and neuro-protective factors. Derived cell products were immunologically 
and molecularly characterized for neural lineage commitment. In-vivo studies of SDIA-
induced products were conducted in the mouse model of brain ischaemia induced by 
transient BCCAO and reperfusion. Behavioural assessment of ischaemic mice post-
transplant into the striatum was performed in the water maze system. Tracking of 
bromodeoxyuridine-labelled products was made on brain sections and teratoma was 
examined. 
Figure 1 and Figure 2 depict the strategic plan and analyses of the in-vitro and in-
vivo studies in the project. The maintenance culture condition of undifferentiated mouse 
ES cell lines, D3 and E14TG2a, were optimized by testing the effects of three different 
serum from two companies (Gibco and Hyclone), and two different feeders PMEF and 
STO on the cell number, cell viability and SSEA-1 positivity. 
Subsequently the undifferentiated ES cells were propagated for differentiation-
j 
induction of the neural lineage. Two main strategies were used. The first one involved 
the formation of embryoid bodies from ES cells under the influence of retinoic acid. The 
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second one involved the use of SDIA, in which ES cells were co-cultured with three 
different cell lines, a neural progenitor cell line CI7.2 and an adiposal cell line and its 
derivative, L cells and L-Wnt-3A cells. The ES-derived products were characterized 
morphologically, immunologically and genetically. 
After in-vitro induction, the functionality of the SDIA-induced cell products, 
which has the largest proportion of nestin-positive colonies, was investigated in the 
ischaemic-induced mice model. BrdU-labelled cell products were intracranially 
implanted onto the straitum of six ischaemic mice. Behavioral improvements of three 
groups of mice, including six normal mice, six ischaemic mice and six transplanted 
ischaemic mice, were assessed by a water maze system for 5 days. After assessment, all 
mice were sacrifled and their brains were isolated and stored in either OCT medium or 
paraffin blocks. Sections at different positions were made and were subjected to 
hematoxylin and eosin staining and BrdU-immunostaining for histological analysis. 
,1 
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Figure 2 The scheme of in-vivo studies 
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Chapter 3 Materials and Methods 
3.1 Chemicals and Reagents 
3.1.1 Cell Culture 
The followings were used for propagation, induction and differentiation of ES cells. 
• Acetic acid, glacial (Cat. 1.00063.2500, Merck & Co., Inc, USA) 
• K\\-trans Retinoic acid, powder (Cat. R2625, Sigma-Aldrich Corporation, Saint 
Louis, Missouri, USA) 
• B27 supplement, SOX (Cat. 17504-044, Gibco, Invitrogen Corporation, London, 
UK) 
• Dimethyl sulfoxide (DMSO; Cat. WAK-DMSO-10，Cryosure, Amphi Ltd., Turkey) 
• Dulbecco's Phosphate-Buffered Saline, IX, liquid (Cat. 14190-136, Gibco, 
Invitrogen Corporation, London, UK) 
• Fibronectin from bovine plasma, 0.1% (Cat. F1141, Sigma-Aldrich Corporation, 
Saint Louis, Missouri, USA) 
• Foetal calf serum, Qualified, 500mL (Cat. 26140-079, Gibco, Invitrogen 
Corporation, London, UK) 
• Gelatin powder (Cat. 101186M, BDH, Merck & Co., Inc, USA) 
• Geneticin, Selective Antibiotic, powder (Cat. 11811-031, Gibco, Invitrogen 
Corporation, London, UK) 
• Glycerol (Cat. 101186M, BDH, Merck & Co., Inc, USA) 
• Hamilton syringe, lOuL (Cat. 80330； Hamilton Company, Nevada, USA) 
• Insulin-Transferrin-sodium Selenite media supplement, powder (Cat. II884，Sigma-
Aldrich Corporation, Saint Louis, Missouri, USA) 
• Ketamine, 10% (Alfasan, FarmaVet SA, Romania) 
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• Knockout Dulbecco's Modified Eagle's Medium (Cat. 10829-018, Gibco, 
Invitrogen Corporation, London, UK) 
• Knockout Serum Replacer (Cat. 10828-028, Gibco, Invitrogen Corporation, 
London, UK) 
• Laminin from Engelbreth-Holm-Swarm Murine sarcoma (basement membrane) 
(Cat. L2020, Sigma-Aldrich Corporation, Saint Louis, Missouri, USA) 
• Leukemia inhibitory factors (Cat. CMI-LIF2010, Chemicon, Chemicon 
International, Inc., Boronia Victoria, Australia) 
• L-Glutamine-200 mM (lOOX), liquid (Cat. 14190-136, Gibco, Invitrogen 
Corporation, London, UK) 
• MEM Non-Essential Amino Acids Solution 10 mM (lOOX), liquid (Cat. 11140-050’ 
Gibco, Invitrogen Corporation, London, UK) 
• Mercaptoethanol, beta (Cat. M7522, Sigma-Aldrich Corporation, Saint Louis, 
Missouri, USA) 
• Mitomycin C from Streptomyces caespitosus, powder (Cat. M4287, Sigma-Aldrich 
Corporation, Saint Louis, Missouri, USA) 
• N2 supplement, lOOX (Cat. 17502-048, Gibco, Invitrogen Corporation, London, 
UK) 
• Neurobasal medium (Cat. 21103-049, Gibco, Invitrogen Corporation, London, UK) 
• Penicillin-Streptomycin, liquid (Cat. 15140-122, Gibco, Invitrogen Corporation, 
London, UK) 
• Poly-L-omithine Solution 0.01%, Sterile-filtered (Cat. P4957, Sigma-Aldrich 
Corporation, Saint Louis, Missouri, USA) 
• Trypan Blue (Cat. 07050, Stem Cell Technologies, North America) 
• Trypsin-Ethylenediaminetetraacetic Acid (EDTA), 0.05%, IX (Cat. 25300-054, 
Gibco, Invitrogen Corporation, London, UK) 
• Trypsin-EDTA, 0.25%, IX (Cat.' 15050-057, Gibco, Invitrogen Corporation, 
London, UK) ‘ 
• Xylazine, 2% (Alfasan, FarmaVet SA, Romania) 
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3.1.2 Immunohistocliemistry and staining 
The followings were for immunophenotyping and staining of ES cells and their derived 
products. 
• 4’，6'-diamidino-2-phenylindole hydrochloride (Cat. HI200, Vector Laboratory Inc., 
California, USA) 
• Aminopropyl triethoxy-silane, APES (Cat. A3648, Sigma-Aldrich Corporation, 
Saint Louis, Missouri, USA) 
• BrdU, colorimetric, lOOOX (Cat. 1647229, Roche Applied Science, Basel, 
Switzerland) 
• Eosin Yellowish (Cat. 34197, BDH, Merck & Co., Inc, USA) 
• Fluorescein isothiocyanate (FITC) anti-BrdU (Cat. 1202693, Roche Applied 
Science, Basel, Switzerland) 
• FITC Goat anti mouse IgG (H+L) Conjugate (Cat. 816511, Zymed Laboratory Inc. 
(Invitrogen Corporation), London, UK) 
• FITC Goat anti mouse IgM (m chain specific; Cat, 626811, Zymed Laboratory Inc. 
(Invitrogen Corporation), London, UK) 
• Normal Goat Serum (Cat. 01-6201, Zymed Laboratory Inc. (Invitrogen 
Corporation), London, UK) 
• Haematoxylin Hydrate (Cat. 34037’ BDH, Merck & Co” Inc, USA) 
• Monoclonal antibody to TuJ III perufied antibody (Cat. 11-264-ClOO, Exbio 
antibodies, Vestec Czech Republic) 
• Monoclonal mouse anti-GFAP antibody (Cat. 18-0021, Zymed Laboratory Inc. 
(Invitrogen Corporation), London, UK) 
• Monoclonal mouse anti-MAP-2 antibody (Cat. 131500, Zymed Laboratory Inc. 
(Invitrogen Corporation), London, UK) 
• Monoclonal mouse anti-Nestin antibody (Cat. 611659, Pharmingen, BD 
Transduction Laboratories, CA，USA) 
• Monoclonal Mouse anti-Oct-4 antibody (Cat. sc-5279, Santa Cruz, Santa Cruz 
Biotechnology Inc., CA, USA) 
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• Monoclonal Mouse anti-SSEA-1 antibody (Cat. sc-21702, Santa Cruz, Santa Cruz 
Biotechnology Inc., CA, USA) 
• Monoclonal Mouse anti-Tumor rejecting antigen 1-81 (Tral-81) antibody (Cat. sc-
21706, Santa Cruz, Santa Cruz Biotechnology Inc., CA, USA) 
• Mouse anti-TH antibody (Cat. 32-2100, Zymed Laboratory Inc. (Invitrogen 
Corporation), London, UK) 
• Paraformaldehyde, crystalline (Cat. P6148, Sigma-Aldrich Corporation, Saint Louis, 
Missouri, USA) 
• Phenylenediamine (Cat. P6001, Sigma-Aldrich Corporation, Saint Louis, Missouri, 
USA) 
• Popidium Iodide (Cat. P3556, Sigma-Aldrich Corporation, Saint Louis, Missouri, 
USA) 
• Purified anti-human MBP antibody (Cat. 559904, Pharmingen, BD Bioscience, CA, 
USA) 
• Tetramethylrhodamine isothiocyanate (TRITC) goat anti-mouse IgG (H+L) 
Conjugate (Cat. 816514, Zymed Laboratory Inc. (Invitrogen Corporation), London, 
UK) 
• Triton X-100 (Cat. T8787, Sigma-Aldrich Corporation, Saint Louis, Missouri, USA) 
• Xylene (Cat. 8681，Merck & Co., Inc，USA) 
3.1.3 Molecular Biology 
The followings were used for RNA extraction, reverse transcriptase polymerase chain 
reaction (RT PCR) and visualization of gene products. 
• lOX PCR buffer-MgCl2 (Cat. Y02028, Gibco, Invitrogen Corporation, UK) 
• lOX Stratascript (Cat. 600085-52, Stratagene Corporation, California, U S A ) 
• DNA ladder (Cat. SM0243, MBI, Fermentas Life Sciences, Burlington, Canada) 
• Deoxynucleoside Triphosphate (Cat. R0192, MBI, Fermentas Life Sciences, 
Burlington, Canada) 
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• Eithidium bromide (Cat. 2515, Sigma-Aldrich Corporation, Saint Louis, Missouri, 
USA) 
• MgCl2 50mM (Cat. Y02016, Gibco, Invitrogen Corporation, London, UK) 
• Platinum Taq DNA polymerase (Cat. 10966-034, Gibco BRL, Invitrogen 
Corporation, London, UK) 
• Reverse Transcriptase (Cat. 600085-51, Stratagene Corporation, California, USA) 
• Rnase inhibitor (Cat. N211B, Promega Corporation, Madison (New York), USA) 
• Ribonucleic acid (RNA) RNeasy Extraction Mini Kit (Cat. 74106，Qiagen Pty Ltd, 
Victoria, Australia) 
• Superscript II Rnase H (Cat. 18064-071, Gibco, Invitrogen Corporation, London, 
UK) 
• Tris-Acetic acid-EDTA Buffer Solution, TAE, SOX (Cat. 24710-030, Gibco, 
Invitrogen Corporation, London, UK) 
• Tween-20 (Cat. PI379’ Sigma-Aldrich Corporation, Saint Louis, Missouri, USA) 
3.2 Consumable 
- The following items were general consumables used in this project. 
• Flasks Nunclon with Filter Caps, SOcm?, Polystyrene, Sterile (Cat. 178891, Nunc, 
Denmark) 
• Tissue culture dish, 100 x 20mm (Cat. 430167, Coming Incorporated, New York, 
USA) 
• Culture plate, 6-well, with lids, sterile (Cat. 140675, Multidishes Nunclon, Nunc, 
Denmark) ‘ 
• Culture plate, 12-well, with lids, sterile (Cat. 140675, Multidishes Nunclon, Nunc, 
Denmark) 
• Culture plate, 24-well, with lids, sterile (Cat. 142475, Multidishes Nunclon, Nunc, 
Denmark) 
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• Ultra-low attachment polystyrene 6-well culture plate (Cat. 3471, Coming 
Incorporated, New York, USA) 
• Ultra-low attachment polystyrene 24-well culture plate (Cat. 3473, Coming 
Incorporated, New York, USA) 
• Petri dish, with triple vents, 94 x 15mm (Cat. 633185, Greiner, Greiner Bio-one, 
Frickenhausen, Germany) 
• Non-treated Flasks, 25cm^, Polystyrene, Sterile (Cat. 169900, Nunc, Denmark) 
• Thincert cell culture insert for 12 well plates with transparent membrane 
(PET) ,with pore size: 0.4 \im (Cat. 16670, Greiner, Greiner Bio-one, 
Frickenhausen, Germany) 
• Thincert cell culture insert for 6 well plates with transparent membrane (PET) ’with 
pore size: 0.4 |im (Cat. 16669, Greiner, Greiner Bio-one, Frickenhausen, Germany) 
• Cell culture flask, 75cm^, with filter, sterile (Cat. 658175, Greiner, Greiner Bio-one, 
Frickenhausen, Germany) 
• Cell culture flask, 25cm^,with filter, sterile (Cat. 690275, Greiner, Greiner Bio-one, 
Frickenhausen, Germany) 
• Pipette, 2mL (Cat. PN2E1, Orange, AM Plus Company, HK) 
• Pipette, 5mL (Cat. PN5E1, Orange, AM Plus Company, HK) 
• Pipette, lOmL (Cat. PNlOEl, Orange, AM Plus Company, HK) 
• Polypropylene Round-Bottom Test Tube, snap cap, 5 mL, 12x75 mm (Cat. 352063, 
. BD Falcon, BD Biosciences, CA, USA) 
• Universal bottle (Cat. BS128A, Sterilin, Barloworld Scientific Ltd., Staffordshire, 
UK) 
• 50mL Centrifuge tube, Polypropylene (Cat. 210261, Greiner, Greiner Bio-one, 
Frickenhausen, Germany) 
• Cell Strainer, 40um (Cat. 352340, BD Falcon, BD Biosciences, CA, USA) 
• Cell Scrapers (Cat. 179707, Nunc, Denmark) 
• Cryotube, internal thread, Polypropylene, and screw stopper, Sterile (Cat. 377267, 
Nunc, Denmark) 
• Cover glass, 12mm circular (Cat. CM120RA1, Gerhard Menzel,Germany) 
• • Parafilm (Cat. PM996, Parafilm, South East Chem. and Instm Ltd, HK) 
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• Syringe, 25 gauge, ImL (Cat. BND305125, Becton Dickinson, BD Bioscience, 
New Jersey, USA) 
• Filter Syringe 0.22|Lim Polyethersulfone, Sterile (Cat. SLGP033RS, Millipore 
Corporation, Billerica, USA) 
• Microscope slides (Cat. 7101，Sail Brand, China) 
3.3 Cell lines 
3.3.1 Feeder cells 
3.3.1.1 Primary mouse embryonic fibroblasts 
Primary mouse embryonic fibroblasts (PMEF) were isolated from embryos of 
C57BL/6 pregnant mice 13.5 to 14.5 days post coitus (dpc). They were eight to nine 
weeks old and were bred in the Laboratory Animal Services Centre of the Chinese 
University of Hong Kong. The appearance of vaginal plugs was designated as day 0 of 
gestation. PMEF were maintained at a relatively high density of 1 x lOVmL. PMEF 
which were passaged for three to six times were ready for use. 
3.3.1.2 STO 
STO (CRL-1503, American Type Culture Collection, Manassas, Virginia, USA) 
was derived from a continuous line of SIM mouse embryonic fibroblasts. They are 
adhesive and fibroblast in morphology. 
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3.3.1.3 L Cells 
L Cells (CRL-2648, American Type Culture Collection, Manassas, Virginia, 
USA) is a cell line isolated from the subcutaneous connective tissue, areolar and adipose 
of C3H/An strain mice. They are adhesive and fibroblast in morphology. It is the 
parental line for the L Wnt-3A cell line, which was transfected with Wnt-3A expression 
vector and acts as a control of L-Wnt-3A. 
3.3.1.4 L-Wnt-3A Cells 
L-Wnt-3A (CRL-2648, American Type Culture Collection, Manassas, Virginia, 
USA) secretes the biologically active Wnt-3A protein and was established from a stable 
clone of L cells transfected with Wnt-3A expression vector in G418 selective medium. 
The Wnt-3A gene encodes a secreted glycoprotein with a variety of signaling effects. 
Wnt genes control many patterning and growth events during embryonic development. 
They are adhesive and fibroblast in morphology. 
3.3.1.5 C17.2 
CI7.2 is a cell line that generated by retrovirus-mediated v-myc transfer into 
progenitors cultured from neonatal mouse cerebellum. They are adhesive and neuronal 
d 
morphology. The multipotent neural progenitor cell line was a kind gift from the late Dr. 
David Walsh, Department of Anatomy, University of New South Wales, Australia. 
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3.3.2 ES cells 
3.3.2.1 ES-D3 
ES-D3 (CRL-1934, American Type Culture Collection, Manassas, Virginia, 
USA) is a mouse ES cell line isolated from the blastocyst of 129/Sv+c/+p strain mice. 
Single undifferentiated D3 is epithelial in morphology. When injected into blastocysts, 
D3 can colonize the germline and reconstitute a mouse. The number of passage was not 
available. 
3.3.2.2 ES-E14TG2a 
ES-E14TG2a (CRL-1821, American Type Culture Collection, Manassas, 
Virginia, USA) is a mouse ES cell line isolated from the blastocyst of 129/Ola strain 
mice. Single undifferentiated E14TG2a is spherical in morphology. The cells are 
deficient in hypoxanthine guanine phosphoribosyl transferase and are resistant to 0.06 
mM 6-thioguanine. When injected into blastocysts, E14TG2a can colonize the germline. 
The number of passage was not available. 
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3.4 In-house prepared solutions 
3.4.1 Stock solution of Insulin, Transferrin, Selentine (ITS) Supplement 
ITS supplement powder (Cat. II884, Sigma) 5g 
Glacial acetic acid (Cat. 1.00063.2500, Merck) 0.2mL 
Sterile double-deionized water 5mL 
The solution was filter-sterilized and made up to volume of 50 mL with sterile double-
deionized water. Aliquots were kept at -80°C until use for no more than 3 months. 
3.4.2 Enriched Knock-Out Dulbecco's Modified Eagle's Medium (KO DMEM) 
KO DMEM (Cat. 10829-018, Gibco) 500mL 
L-Glutamine-200 mM, lOOX (Cat. 14190-136, Gibco) 5mL 
Penicillin-Streptomycin (Cat. 15140-122, Gibco) 5mL 
Aliquots were kept at -80°C until use for no more than 1 month. 
3.4.3 Mitomycin C solution 
Mitomycin C (Sigma, USA) 2mg 
Enriched KO DMEM 1 OmL 
The solution was filter-sterilized. Aliquots were kept at -80°C until use for no more than 
30 days. 
3.4.4 Gelatin solution 0.1% 
Gelatin powder (Merck & Co.，USA) 0.5g 
Sterile double-deionized water 500 mL 
The solution was warmed at 37^C until complete dissolution. The solution was 
autoclaved and aliquoted were kept at -80°C until use for no more than 30 days. 
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3.4.5 p-mercaptoethanol solution 
3.4.5.1 p-mercaptoethanol solution O.IM 
p-mercaptoethanol (14.33M) (Cat. M7522, Sigma) ImL 
Sterile double-deionized water 13.3mL 
3.4.5.2 p-mercaptoethanol solution O.IM 
1M p-mercaptoethanol ImL 
Sterile double-deionized water 9mL 
3.4.5.3 p-mercaptoethanol solution O.IM for preparation of culture medium 
O.IM P-mercaptoethanol 1 mL 
Enriched KO DMEM 9mL 
The solution was freshly prepared for preparation of medium. 
3.4.6 ALL-trans retinoic acid 
3.4.6.1 ALL-trans retinoic add stock solution 0.01 M 
ALL-trans RA powder (Molecular Weight = 300.4; Cat. R2625, Sigma) 0.03g 
Absolute ethanol 1 OmL 
The solution was filter-sterilized. Aliquots were kept at -80®C until use for no more than 
14 days. 
3.4.6.2 AAAj-trans retinoic acid working solution l | iM 
O.OIM ALL-trans RA stock lOOul 
'' Dulbecco's Phosphate-Buffered Saline (DPBS; Cat. 14190-136, Gibco) 9.9mL 
Aliquots were kept at -80°C in dark until use for no more than 7 days. 
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3.4.7 Paraformaldehyde solution 4% (PFA) 
Paraformaldehyde (PFA; Cat. P6148, Sigma) 4g 
DPBS (Cat. 14190-136, Gibco) lOOmL 
The solution was warmed at 55°C-60°C until complete dissolution. The solution was 
kept in dark at -80°C until use for no more than 30 days. 
3.4.8 Tritox X-100 solution 
3.4.8.1 Tritox X-100 solution 3% 
Triton X-100, 100% (Cat. T8787, Sigma) 300ul 
DPBS (Cat. 14190-136，Gibco) 9.7mL 
The solution was kept in dark at room temperature until use for no more than 30 days. 
3.4.8.2 Tritox X-100 solution 0.3% 
3% Triton X-100 ImL 
DPBS (Cat. 14190-136，Gibco) 9mL 
The solution was kept in dark at room temperature until use for no more than 30 days. 
3.4.9 Popidium iodide solution lug/mL (PI) 
Phenylenediamine (PI; Cat. P6001, Sigma) 1 OOmg 
Glycerol (Cat. 101186M, BDH) 90mL 
DPBS (Cat. 14190-136, Gibco) lOmL 
Popidium Iodide (Cat. P3556, Sigma) lOul 
The solution was stirred thoroughly and pH was adjusted to 8.0 with 0.5M 
hydrocarbonate acid pH9.0. Aliquots were kept at -20®C in dark until use for no more 
than 1 year 
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3.4.10 Geneticin solution 
3.4.10.1 Geneticin solution 50mg/mL 
G418 powder (Cat. 11811-031, Gibco) 50mg 
DPBS (Cat. 14190-136, Gibco) lOmL 
The solution was filter-sterilized. Aliquots were kept at -80''C until use for no more than 
14 days. 
3.4.10.2 Geneticin solution 5mg/mL 
Geneticin solution 50mg/mL ImL 
DPBS (Cat. 14190-136, Gibco) 9mL 
Aliquots were kept at -80�C until use for no more than 14 days. 
3.4.11 Poly-L-ornithine solution 
Poly-L-omithine Solution 0.01% (Cat. P4957, Sigma) 4mL 
Sterile double-deionized water 22.6mL 
3.4.12 Laminin solution 
Laminin (Cat. L2020, Sigma) 25uL 
DPBS (Cat. 14190-136, Gibco) 25mL 
45 
3.4.13 Maintenance medium for cell feeders 
KO DMEM (Cat. 10829-018, Gibco) 400mL 
Foetal Calf Serum (FCS), qualified (Cat. 26140-079, Gibco) 75mL 
L-Glutamine-200 rtiM, lOOX (Cat. 14190-136, Gibco) 5mL 
Penicillin-Streptomycin, (Cat. 15140-122, Gibco) 5mL 
Non-Essential AA Solution 10 mM, lOOX (Cat. 11140-050, Gibco) 5mL 
p-mercaptoethanol (O.IM) 1 OmL 
Aliquots were kept at -20�C until use for no more than 1 month. 
3.4.14 Mitomycin C inactivation medium 
KO DMEM (Cat. 10829-018, Gibco) 450mL 
FCS, qualified (Cat. 26140-079，Gibco) 25mL 
L-Glutamine-200 mM, lOOX (Cat. 14190-136, Gibco) 5mL 
Penicillin-Streptomycin, (Cat. 15140-122, Gibco) 5mL 
Non-Essential AA Solution 10 mM, lOOX (Cat. 11140-050，Gibco) 5mL 
p-mercaptoethanol (O.IM) lOmL 
Aliquots were kept at -20°C until use for no more than 1 month. 
5.4.15 Freezing medium 
KO DMEM (Cat. 10829-018, Gibco) 4mL 
FCS, qualified (Cat. 26140-079，Gibco) 4mL 
DMSO (Cat. WAK-DMSO-10，Cryosure) 2mL 
The freezing medium was freshly prepared. DMSO was added to the chilled medium. 
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3.4.16 Propagation medium for ES cells 
There are two available propagation media for ES cells namely; serum-based 
medium allowing a rapid growth but more difficult to control the undifferentiated status 
and serum-free medium yielding in a slower growth. 
3.4.16.1 Serum-based propagation medium for ES cells 
KO DMEM (Cat. 10829-018, Gibco) 400mL 
ES Cell-Qualified FCS (Cat. 10439-024, Gibco) 75mL 
L-Glutamine-200 mM, lOOX (Cat. 14190-136, Gibco) 5mL 
Penicillin-Streptomycin, (Cat. 15140-122, Gibco) 5mL 
Non-Essential AA Solution 10 mM (100X)(Cat. 11140-050, Gibco) 5mL 
P-mercaptoethanol (O.IM) 1 OmL 
Aliquots were kept at -20°C until use for no more than 1 month. lOOOIU/mL LIF (Cat. 
CMI-LIf2010, Chemicon) was added before used. 
3.4.16.2 Serum-free propagation medium for ES cells 
KO DMEM (Cat. 10829-018, Gibco) 400mL 
Knock Out Serum Replacor (SR; Cat. 10828-028, Gibco) 75mL 
“ L-Glutamine-200 mM, lOOX (Cat. 14190-136, Gibco) 5mL 
Penicillin-Streptomycin, (Cat. 15140-122, Gibco) 5mL 
Non-Essential AA Solution 10 mM, 1OOX (Cat. 11140-050, Gibco) 5mL 
Beta mercaptoethanol (O.IM) 1 OmL 
Aliquots were kept at -20�C until use for no more than 1 month. lOOOIU/mL LIF was 
added before used. ‘ 
ii 
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3.4.16.3 Serum-free induction medium for ES cells 
3.4.16.3.1 Serum-free induction medium I 
KO DMEM (Cat. 10829-018, Gibco) 410mL 
KO SR (Cat. 10828-028, Gibco) 75mL 
L-Glutamine-200 mM, lOOX (Cat. 14190-136, Gibco) 5mL 
Penicillin-Streptomycin, (Cat. 15140-122, Gibco) 5mL 
Non-Essential AA Solution 10 mM, lOOX (Cat. 11140-050, Gibco) 5mL 
Aliquots were kept at -20�C until use for no more than 1 month. 
3.4.16.3.2 Serum-free induction medium II 
Insulin, Transferrin, Selentine and Fibronectin (ITSFn) medium 
Enriched KO DMEM 98.9mL 
Insulin, Transferrin, Selentine (ITS) Supplement ImL 
Fibronectin (Fn) from bovine plasma (Cat. F1141，Sigma) 1 OOuL 
The ITSFn medium was freshly prepared by supplementing fibronectin solution 
immediately before use. 
3.4.16.3.3 Serum-free induction medium III 
N2-/B27-supplemented Neurobasal medium (N2B27) 
Neurobasal medium (Cat. 21103-049，Gibco) 38.8mL 
L-Glutamine-200 mM, lOOX (Cat. 14190-136, Gibco) 0.4mL 
Penicillin-Streptomycin, (Cat. 15140-122, Gibco) 0.4mL 
B27 supplement, SOX (Cat. 17504-044, Gibco) 80uL 
„ N2 supplement, lOOX (Cat. 17502-048，Gibco) 320uL 
The N2B27 medium should be kept at 4°C, and used within 1 week. 
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3.5 Equipments 
Below were equipments used throughout the whole project. 
• Bench-top Centrifuge (Model: CR412, Jouan, Thermo Electron's Corporation, New 
York, USA) 
• Ohaus Analytical Plus Balance (Model: AP250D, OHAUS, New Jersey, USA) 
• Ohaus Harvard Trip Balance (Model: 1450-SD, OHAUS, New Jersey, USA) 
• Water Jacketed C02 Incubator with HEPA filter (Model: Series II 3111, Thermo 
Forma, Thermo Electron's Corporation, New York, USA) 
• Biological safety cabinet (Model: 1185, Thermo Forma, Forma Scientific, Inc., 
New York, USA) 
• Inverted microscope (Model: 1X71, Olympus, Olympus Corporation, Tokyo, Japan) 
• Coulter haematology analyzer (Model: AcT Diff, Coulter Corporation, Miami, 
USA). 
• Spectrophotometer (GeneQuant II, Pharmacia LKB Biochrom Ltd., Cambridge, 
England) 
• Programmable Thermal controller (Model: PTC-100, Hoefer Scientific Instruments, 
San Franciso, USA) 
• Vortex Mixer (Model: M37615, Thermolyne, Bamstead International, USA) 
. • Bench top and refrigerated centrifuges (Model: 5417c, Eppendorf International, 
Hamburg, Germany) 
• Rotary Microtome (Model: RM2035, Leica, Germany) 
• Watermaze System (Model: 1030120 (SH-1), Shanghai Xi Bo Biotechnology Ltd, 
Shanghai, China) 
• Stereotaxic Frame (Model: 900，KOPF, California, USA) 
• Mouse Adaptor (Model: 921-E, KOPF, California, USA) 
- • Mouse Ear Bars (Model: 921 -F&G，KOPF, California, USA) 
,1 • Volvere-GX, handpieces (Model: GX-35EM, Nakanishi, Inc, Japan) 
• Laboratory gasbumer, gasprofi ISCS (ModeL6.103.000, WLD-TEC, Techcomp 
Ltd., North America) 
• Cytocentrifuge (Model: Autosmear CF-120, Sakura Seiki Co., Tokyo, Japan) 
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• y-irradiator (Gammacell 1000 Elite #214，MDS Nordion, Canada) 
• Neubauer hemocytometer, improved 
• Instant camera (Polaroid DS34, St. Albans, Hertfordshire, England) 
• Electrophoresis documentation and analysis system (Eastman Kodak Company, 
Rochester, NY, USA) 
3.6 Methods 
3.6.1 Cell Culture 
All culture works were aseptically performed in a biological safety cabinet. 
Stringent measures were implemented to avoid microbial contamination and cross 
infection according to the policies and procedures stipulated by the Chinese University 
of Hong Kong and Prince of Wales Hospital, Hospital Authority. 
3.6.1.1 Preparation of round cover-slips 
»� 
Round glass covers-lips of 12-mm diameter were dipped into 70% ethanol and 
then flamed in Bunsen burner. Sterilized cover-slips were individually and aseptically 
transferred into wells of 24-well tissue culture plate. 
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3.6.1.2 Gelatinization of tissue culture wares 
Coating of tissue culture wares with gelatin facilitates better adhesion. Three mL 
of 0.1% gelatin solution were distilled into 25cm^ flasks, whereas six mL were 
dispensed to 75cm^ flasks or 100 mm tissue culture dishes. They were allowed to stand 
for at least 20 minutes at ambient temperature. Gelatin solution was aspirated off. Air-
dried tissue wares were kept at 4®C until use for no more than a month (Pollard 1997; 
Zigova et al. 2002). 
3.6.1.3 Poly-L-ornithine and laminin coating 
One mL of freshly prepared 0.01% poly-L-omithine in sterile doubled de-ionized 
water was dispensed into each well of tissue culture plates with or without the insertion 
of sterile round cover-slip. The plate was incubated for an hour at 3TC and was then 
washed thrice with sterile DPBS for five minutes each. One mL of lug/mL laminin in 
•sterile DPBS was added. The plate was further incubated for an hour at 37°C. Upon 
completion of washing with DPBS, plate was ready for use. 
3.6.1.4 Thawing frozen cells 
A frozen ampoule of stromal feeder cells wrapped in a sterile plastic bag was 
J 
quickly thawed within 2 minutes in a 37°C-water bath with gentle agitation. The de-
froze cell suspension were diluted drop-wise with lOmL of ice-cold fibroblast medium 
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and allowed to equilibrate for 10 minutes at 4�C. Thereafter, cell suspension was spun at 
250 X g for eight minutes at ambient temperature and supernatant was discarded. The 
cell pellet was re-suspended and adjusted to 1 x lOVmL with fibroblast medium and 
plated onto gelatinized 75 cm flasks or 100mm tissue culture dishes. Cultures were 
maintained at 3TC in a humidified 5% C02-incubator. Medium was changed overnight 
and cultures were maintained until confluency. 
3.6.1.5 Passage of adherent culture 
Confluent cultures of adherent cells were washed twice with DPBS and were 
enzymatically digested with 0.05% trypsin containing 0.53 fiM EDTA at 3TC for five 
minutes or until cell detachment was evident. Trypsinization was stopped with twice 
volumes of fibroblast medium. Cell suspension was dislodged and triturated using a 
fine-pored pipette. Cells were counted. 
3.6.1.6 Cell count 
Automated cell counts were generated using the Coulter haematology analyzer. 
Cell suspensions of counts below the sensitivity limit were counted manually using an 
improved Neubauer hemocytometer under a microscope. Appropriate dilution of cell 
suspension was made so that each mm^ grid area of the four comers accommodated 
J _ 'y 
approximately 100 cells. Cells in the eight mm area were counted using lOx objective 
of microscope. The mean cell concentration was calculated. 
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3.6.1.7 Cytospin 
Cell suspension was adjusted to 1 x lOVmL in DPBS supplemented with 1% 
bovine serum albumin. A hundred uL of the cell suspension was dispensed to the cyto-
housing and spun at 25 x g for five minutes onto a glass slide. Slides were air-dried, 
wrapped with aluminum foil and kept at -80®C until analysis. 
3.6.1.8 Cell viability test 
One fifth volume of tryphan blue dye solution was added to the cell suspension. 
A minimum of 500 unstained viable cells and stained dead cells were counted using an 
improved Neubauer hemocytometer. Cell viability was expressed as a percentage of the 
total cells counted. 
3.6.1.9 Cryopreservation 
Cell suspension of 2 x lOVmL was mixed with equal volume of freezing medium 
and was aliquoted into cryo-vials. They were then put into a pre-cooled styrofoam box 
and kept in an ultra-low freezer at -80°C freezer overnight. Frozen cells were transferred 
to a liquid nitrogen tank for long-term storage. 
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3.6.1.10 Preparation of primary mouse embryonic fibroblast (PMEF) 
Mouse embryonic fibroblasts were isolated from embryos derived from pregnant 
mice 13.5 to 14.5 dpc supplied by the Laboratory Animal Services Centre of the Chinese 
University of Hong Kong. Mice were sacrificed by cervical dislocation. The mice were 
laid on its back and the abdomen was disinfected with 70% ethanol. With sterilized 
dissecting instruments (fine scissors, tweezers, razor blades and forceps), the uterine 
horns were dissected. They were rinsed briefly in 70% ethanol and placed onto a Petri 
dish containing sterile DPBS. Embryos were separated from the placenta and 
surrounding membranes and transferred to a second Petri dish with sterile DPBS. The 
head, liver and heart of the embryo were carefully removed. The remaining body was 
washed with fresh DPBS to remove as much blood as possible. In a minimal volume of 
DPBS, the embryonic body was finely minced into many small pieces using razor blades 
and scissors until being pipettable. Excessive DPBS was removed after centrifugation at 
250 X g for 10 minutes. The cell suspension was enzymatically digested in 0.25% 
'trypsin solution containing 0.53 i^M EDTA for approximately 15 minutes in a 37°C 
water bath with constant agitation. At five-minute intervals, the cell suspension was 
vortexed for 30 seconds. Trypsinization was stopped by adding double volumes of 
fibroblast medium. Tissues in large pieces were mechanically dissociated by pipetting 
up and down through a 5-mL pipette. The cell suspension was allowed to stand for two 
minutes to sediment large pieces of cellular aggregates. The supernatant was transferred 
into a new tube and pelleted at 250 x g for 10 minutes. Cells were re-suspended in fresh 
medium and triturated through a fine-pored pipette. Cells segregated from five embryos 
54 
were sufficient to seed a 75cm^ flask and cultures were incubated for 2-3 days at 3TC in 
a humidified 5% C02-incubator. Confluent growth of PMEF, which was regarded as PO, 
took place in three to four days. Cultures were then passaged, split into two to three 
flasks or kept as frozen stock (Joyner 1999). 
3.6.1.11 Mitomycin C inactivation of feeder cells 
Cultures of approximately 90% confluency were treated with 10 fag/mL 
Mitomycin C for 2.5 hours to arrest cell division by inhibiting DNA synthesis and 
nuclear division. Treated cultures were washed twice with DPBS and trypsinized. Cell 
suspensions of 8 x 10^ 1.5 x 10^ and 3 x 10^ in fibroblast medium were seeded onto 12-
well, 6-well culture insert and gelatinized 75cm^ flask or 100-mm tissue culture dish, 
respectively, and cultured for at least three hours to overnight at 37°C in a humidified 
5% C02-incubator (Joyner 1999). Upon establishment of the feeder layer onto the 
culture ware, cultures were washed once with DPBS before seeding ES cells or 
proceeding to the preparation of CM. 
3.6.1.12 Gamma irradiation of various feeders 
Trypsinized cell suspensions in a 50-mL tube were exposed to 60-Gray 
irradiation in the ^-irradiator. Irradiated cell products were seeded and cultured under 
J 
the same condition of mitomycin C-inactivated cell suspensions. 
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3.6.1.13 Preparation of CM from feeder cells 
Having washed with DPBS, cultures of mitomycin C-inactivated or irradiated 
feeder cells were replenished with serum-free propagation medium and maintained for 
four days at 37�C in a humidified 5% C02-incubator. The CM was collected and spun at 
400 X g for 10 minutes to pellet cellular debris. The supernatant was frozen at -8(fC. 
Collections from six batches of CM were pooled and used thereafter. 
3.6.1.14 Propagation of ES cells in serum-based medium 
ES cell lines, D3 and E14TG2a, were cultured according to the package inserts. 
Frozen ES cells were thawed in 15 rtiL of the serum-based propagation medium 
containing LIF at 1000 units/mL. They were directly plated onto gelatinized culture 
ware pre-established with the inactivated feeder cells of PMEF or STO, and were 
incubated at 37°C in a humidified 5% C02-incubator. Medium was changed once or 
'twice depending on the growth of ES cells and culture was passaged every two days 
(Joyner 1999). 
3.6.1.15 Propagation of ES cell in serum-free medium 
ES cells were thawed and cultured as above-mentioned. On the day of passage, 
ES cells were trypsinized and were replated in 10 rtiL serum-free propagation medium 
supplemented with LIF at 1000 units/mL onto 75cm^ flask or 100-mm tissue culture dish 
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for 45 minutes to an hour to deplete PMEF. Non-adherent cells were enriched upon 
centrifugation at 250 x g for 10 minutes. Cell pellet was dislodged and resuspended. 
Viable ES cells of refractile discoid mononuclear morphology and scanty cytoplasm 
were microscopically counted in an improved Neubauer hemocytometer. Re-plating 
was carried out if the proportion of ES cells was below 60%. Enriched ES cells at 1 x 
lOVmL serum-free propagation serum with 1000 units/mL LIF were seeded onto 
gelatinized culture ware pre-established with the inactivated feeder cells. 
ES cell suspensions of 1 x lOVml in 3 mL, 5 mL and 10 mL were seeded onto 
well of ultra-low adherent 6-well plate, low binding 25cm^ flask and 100-mm Petri dish, 
respectively, without feeder cells. They were incubated at 37°C in a humidified 5% CO2-
incubator. Medium was changed once or twice by discarding spent medium after 
centrifugation at 250 x g for 10 minutes and cell pellet was re-suspended in fresh 
medium. Culture was passaged every two days. 
3.6.1.16 Neural differentiation using ？i\\-trans retinoic acid 
The procedure was basically according to the 4-/4+ induction method of Bain 
and co-workers with minor modifications (Bain et al. 1995). ES cell lines, D3 and 
E14TG2a, which have been propagated on PMEF were enzymatically segregated, 
replated for 45 minutes to deplete feeder cells and seeded in ES cell propagation 
丨^/ 
medium on gelatinized 100-mm tissue culture dish for two days, were induced to form 
EB. ES cells were cultured for four days in the absence of RA followed by four days in 
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the presence of 0.5 mM RA. Control cultures were run in parallel for eight days without 
RA supplement. 
Cultures were trypsinized and triturated to yield a uniform single cell suspension. 
One million cells in lOmL fibroblast medium without LIF and p-mercaptoethanol were 
cultured on a 100-mm diameter bacteriological Petri dish. Medium change was made 
every two days by gentle aspiration of spent medium into a sterile universal bottle. EB 
and cell aggregates were allowed to settle for three minutes. Supernatant was carefully 
removed. Fresh fibroblast medium without LIF and p-mercaptoethanol was replenished. 
Cell suspension was seeded in a new 100-mm diameter bacteriological Petri dish and 
incubated at 37°C in a humidified 5% COz-incubator. On day four, fresh fibroblast 
medium supplemented with 0.5 mM RA was used and changed every two days. Upon 
induction for eight days, cell aggregates were dissociated with 0.25% Trypsin containing 
0.53 |LIM EDTA. Cell suspensions of 5 x 10^ to 1 x in fibroblast medium without 
LIF and P-mercaptoethanol were plated onto poly-L-omithine- and laminin-coated 
coverslips and wells of 24-well tissue culture plate. 
3.6.1.17 Stromal cells-derived inducing activity 
Cultures of mitomycin C-inactivated feeder cells, CI7.2’ L cells and L-Wnt-3A, 
in six-well/12-well cell inserts on culture plates were washed with serum-free induction 
medium-I twice to remove residual serum. Trypsinized ES cells were replated onto 
gelatinized 100-mm tissue culture dish for 45 minutes to deplete feeder cells. One 
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hundred thousand single ES cells were seeded onto feeder cells in serum-free induction 
medium-I and cultured for eight days, followed by six days in serum-free induction 
medium-II (ITSFn medium; Okabe et al. 1996) and four days in serum-free induction 
medium-Ill, respectively. Medium was changed every alternative day. 
For non-contact co-cultures, 1 x 10^ and 1 x 10^ single ES cells in 2.5 mL and 
1.5 rtiL serum-free induction medium-I, respectively, were seeded onto six-well or 12-
well culture plate. Inactivated feeder cells, which were established on 24 mm or 12 mm 
culture inserts a day prior to co-cultures, were washed twice, placed onto the 
corresponding culture plate and filled with 1.5 mL and 0.5 mL serum-free induction 
medium-I, respectively. Cultures were incubated at 37�C in a humidified 5 % CO2-
incubator. Medium was changed every two days. On day four, culture inserts were 
replaced with new ones of confluent growth of freshly mitomycin C inactivated feeders. 
Co-culture was allowed to grow for four more days, followed by six days and four days 
in induction medium-II and in serum-free induction medium-Ill, respectively. Medium 
"was changed every alternative day. 
3.6.1.18 BrdU labeling of the cell products 
Cultures of ES-derived cell products were labelled with BrdU a day before 
transplantation. The induction medium III were replaced by the Induction medium III 
‘ . J 
supplemented with lOuM BrdU. Labeling was allowed for 24 hours (McDonald et al. 
1999). 
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3.6.2 Molecular analysis 
3.6.2.1 RNA extraction 
Total RNA was isolated using RNeasy extraction kit (Qiagen) according to the 
manufacturer's protocol. Pellets of cells were vortexed and lysed in 400 |LIL Lysis 
Buffer RLT which containing guanidine isothiocyanate to protect RNA from 
degradation. 
The mixture was applied to a silica-gel-membrane spin column and centrifuged 
at 8,000 g for 15 seconds. RNA was bound to the resin in the column while other 
metabolites eluted out. The spin column was cleaned with RWl buffer by centrifuging 
at 8,000 g for 15 seconds followed by two washes in RPE buffer at 8,000 g and 20,000 g 
for 15 seconds and three minutes respectively. Total RNA was eluted with 30 |aL 
RNase-free water treated with diethyl-pyrocarbonate (DEPC) into a micro-tube by 
spinning at 8,000 g for one minute and kept frozen at - 8 0 � C until further analysis. 
3.6.2.2 RNA quantitation 
RNA sample was diluted 100 folds in double deionized water. Absorbance 
values at 260 nm and 280 nm were measured against the buffer blank using the 
spectrophotometer. The reading at 260 nm allowed the calculation of the concentration 
of nucleic acid in the sample. An optical density (OD) of one corresponds to 
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approximately 40ng/|LiL for RNA. The ratio between the absorbance values at 260 nm 
and 280 nm gives an estimate for the purity of nucleic acid. Pure preparations of RNA 
had a ratio 1.6 to 2.1. 
3.6.2.3 Reverse Transcription of the First Strand complementary DNA 
Complementary DNA (cDNA) were transcribed from two \xg total RNA with 
100 ng random hexamers and 200 U Superscript reverse transcriptase in 20 \iL reverse-
transcription reaction mix containing 50 rtiM Tris-HCl buffer pH 8.3 at room 
temperature； 75 mM potassium chloride, three mM magnesium chloride, 10 mM 
dithiotreitol, 500 |LIM dNTP，20 U RNase-Inhibitor. RNA and random hexamers were 
first incubated at 70®C for 10 minutes in a thermal cycler and quickly chilled on ice. 
The thermo-profile of cDNA generation was 25�C for 10 minutes, 42°C for 60 minutes, 
95°C for five minutes and ended at 4®C. 
3.6.2.4 Polymerase chain reaction 
Five |LIL reverse-transcription products of the first strand cDNA from RNA 
transcripts were used for amplification of a specific gene sequence in a final 25-\xL 
reaction volume. Table 3 shows details of the genes, primer-pairs, product sizes and 
thermoprofiles of the automated hot-start Polymerase chain reaction (PGR) at 94°C for 
five minutes to restore the activity of the inhibitor-bound polymerase. The reaction mix 
contained 20 mM Tris-HCl buffer pH 8.4，50 mM potassium chloride, 1% Tween-20100 
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\xM of each deoxynucleoside triphosphate (dNTP), six pmoles of each primer, 0.5U 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































3.6.2.5 RNA Integrity Check 
RNA integrity was confirmed by amplifying the reverse-transcription product of 
the first strand cDNA from the ubiquitous mRNA of Glyseraldehyde-3-phosphate 
dehydrogenase (GAPDH). The amplified gene product of 452 bp was obtained with 
primers, ACC ACA GTC CAT GCC ATC AC (sense) and TCC ACC ACC CTG TTG 
CTG TA (anti-sense), upon completion of the 30-cycle amplification of denaturation at 
940c, annealing at 60''C and synthesis at 72°C for 30，30，72 seconds each. Magnesium 
chloride 1.5 mM was used. 
3.6.2.6 Electrophoresis and visualization of gene products 
PGR products and the molecular marker of 100-bp DNA ladder were separated 
and run in 1-2% agarose gel by electrophoresis, stained with ethidium bromide and 
visualized by using the UV transilluminator. Gel images were captured by either the 
‘direct screen instant camera or the electrophoresis documentation and analysis system. 
Results were considered valid if readouts of all replicate analyses were in concordance. 
3.6.3 Immunofluoresent staining 
Upon completion of fixation for 20 minutes in 4% paraformaldehyde (PFA) at 
room temperature, cells were permeabilized for five minutes in 0.3% Tritron-X in PBS. 
Sections were washed thrice in PBS, blocked with 10% normal goat serum (NGS) in 
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PBS at room temperature for 10 minutes, followed by washing thrice with PBS 
containing 1% NGS. Cells were then incubated overnight at 4°C with optimally diluted 
primary antibodies of specificities stipulated in Table 4. After washing thrice with PBS, 
cells were detected by incubating with the pertaining secondary antibodies diluted 100 
folds in 1% NGS in PBS for 30 minutes at room temperature. They were namely FITC-
conjugated goat anti-mouse IgM, FITC-conjugated goat anti-mouse IgG (H+L) and 
TRITC-conjugated goat anti-mouse IgG (H+L). Slides of sections were washed thrice in 
PBS and mounted with anti-fade aqueous mountant containing the fluorescent dye of 
either propidium iodide (PI) or 4',6'-diamidino-2-phenylindole hydrochloride (DAPI) as 
counter-stain. Sections were examined under a fluorescent microscope. 
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Table 4 Specificities and dilutions of primary monoclonal antibodies used in 
immunofluoresent staining. 
Phenotype Specificity Isotype ^^^^^^^^ 
ES eeii Stage-Specific Embryonic antigen-1 IgM 100 
Octamer-binding transcription factor-4 IgG 100 
Tumor rejecting antigen 1-81 IgM 100 
Neural Stem Cell Neuroepithelial stem cell intermediate , ^ 
filament IgG 400 
Neuron _  beta-tubulin class III IgG 1000 
Microtubule-associated Protein 2 IgG 100 
Astrocyte Glial Fibrillary Acidic Protein IgG 50 
DA Neuron Tyrosine Hydroxylase IgG 500 
Oligodendrocyte Myelin Basic Protein IgG 200 
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3.6.4 In-vivo studies 
3.6.4.1 Induction of cerebral ischaemia in mice 
Male ICR mice of mean age 12 weeks and body weight of 25 to 35 g were 
obtained from Laboratory Animal Services Centre of the Chinese University of Hong 
Kong. Global cerebral ischaemia was induced by transient BCCAO of male ICR mice 
having anesthetized by Intraperitoneal injection of 300 |LIL of 1% ketamine and 0.1% 
xylazine in normal saline. A cervical incision was sterilely made on the midline of the 
ventral neck. Bilateral common carotid arteries in the neck were exposed and occluded 
with micro-aneurysm clips for 15 minutes. Thereafter clips were released to allow 
reperfusion. The skin incision was sutured and the mice were allowed to gain access to 
food and water ad libitum in micro-isolator cages. 
3.6.4.2 Transplantation 
One week post-induction of cerebral ischaemia, tested animals were anesthetized 
sedated and fixed to the stereotaxic frame. The stereostaxic co-ordinates were one mm 
anterior and 2 mm lateral to the bregma. The Hamilton syringe was inserted four mm 
into the brain parenchyma from the surface. ES cell-derived products were 
mechanically dissociated into single cell suspension in DPBS and adjusted to 
II 
approximately 1 x 10V|iL. Five pL cell suspension was slowly injected into mice at a 
rate of one |iL per minute. In the sham groups, five \iL DPBS were injected. The needle 
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was slowly drawn after 10 minutes. The hole was cemented and the skin incision was 
sutured. 
3.6.4.3 Assessment of learning ability and memory 
Test and control animals were assessed by using the water maze system which is 
intended to evaluate the learning ability and memory of mice. Basically the maze was 
so constructed with four cue de sacs diverged from the go-through route from the 
starting point to the finishing exit. The system was filled with water to a depth of 15 cm 
to wash out likely body scent which might be regarded as an indicator of way-out by 
mice in subsequent test. The water temperature was maintained at around 26°C. Mice 
of interest were daily trained for three days prior to formal assessments on the two 
consecutive days. The time taken to complete the journey and number of errors 
committed by entering and returning to the dead ends were reckoned. Comparisons 
were made among groups of normal mice, ischaemic mice and ischaemic mice having 
,undergone cellular therapy of ES cell-derived product. 
3.6.5 Histological analysis 
3.6.5.1 Animal sacrifice for brain harvest 
J 
Upon completion of in-vivo monitoring, test and control animals were 
anesthetized. The thoraxes were cut open and animals were trans-cardiacally perfused 
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with 30 mL normal saline. Heads were cut away from the bodies and the whole brains 
were removed quickly and carefully from the skulls. They were then transferred to 
liquid nitrogen or 4% PFA. ‘ 
3.6.5.2 Cryosectioning 
Freshly isolated brains were kept quickly frozen in liquid nitrogen. Blocks of 
tissues embedded in the cryo-mountant OCT were equilibrated for five to ten minutes in 
the microtome. Cryostat sections of 10 to 20 yim in thickness were cut and mounted 
onto superfrost plus slides or slides coated with 3-Aminopropyl triethoxy-silane (APES; 
Cat. A3648, Sigma). Slides were kept at - 8 0 � � u n t i l staining. 
3.6.5.3 Paraffin sectioning 
Freshly removed brains of the tested animals were fixed for three days in 30 mL 
* 4% PFA. They were cut into appropriate sizes and placed in embedding cassettes. The 
tissues were dehydrated sequentially in up-grading concentrations of 70%, 80%, 95% 
ethanol for one hour twice and absolute ethanol for one hour thrice. Brains were then 
subjected to xylene for one hour thrice, 56°C paraffin wax for 1.5 hours twice, before 
final paraffin embedding. . 
,1 
Paraffin blocks of tissues, of either coronal or lateral plan, were cooled down to -
20°C for 20 minutes before trimming. Sections of five to 10 i^m in thickness were cut 
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by using a microtome. They were spread onto surface of water at 45°C. Well spread 
section was transferred onto APES-treated glass slides, air dried and then baked in a 
56"C-oven overnight. Slides were kept at room temperature until use. 
3.6.5.4 Haematoxylin and eosin staining 
Slides of frozen sections were fixed in 10% formalin for 1 minute before staining. 
Paraffin-embedded sections were dewaxed in xylene for five minutes twice. They were 
then re-hydrated in absolute to down-grading 95% and 70% alcohol for five minutes 
twice, two minutes each, respectively. Slides of sections were eventually washed in 
distilled water and stained in Harris hematoxylin solution. After 10 minutes, the 
sections were washed in running tap water for two minutes and rinsed in Scotts' tap 
water for approximately one minute. The sections were washed in running tap water 
again for two minutes, counters-stained in eosin-phloxine solution for three minutes. 
Having rinsed in running water, stained sections were dehydrated in up-grading 
”concentration of 70% and 95% alcohol for two minutes each and absolute ethanol for 
five minutes twice. Sections were then cleared in xylene for five minutes twice and 
mounted using appropriate covers-lips and xylene-based mountant. 
ii 
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3.7 Data analysis 
Non-parametric Mann-Whitney test was used to analyze continuous variables of 
cell nestin-positive colonies. ANOVA was used to examine the incidence of errors 
committed, and time intervals for completion of journey among normal mice, ischaemic 
mice and ischaemic mice having undergone cellular therapy of ES cell-derived product. 
Student's T-test was used to analyze the continuous variable of viability, cell number 
and SSEA-1 positivity. Differences between groups were regarded as significant if p < 
0 . 0 5 . 
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Chapter 4 Results 
4.1 ES cell maintenance 
4.1.1 Serum effect 
Upon thawing, ES cells D3 which were maintained in ES cell propagation 
medium for two days and were then passaged. ES cells of 3 x 10^ were allowed to grow 
in ES cell propagation medium supplemented with three different foetal calf sera at 15% 
(volume/volume) on gelatinized dishes pre-established with confluent growth of 
mitotically inactivated STO. Table 5 shows the numbers of ES cell colonies derived 
from three random fields of lOx objective in three separate experiments. The mean 
number 土 one standard deviation of ES cell colonies in cultures with Hyclone serum 
supplement was 9 ± 1，being significantly fewer than 22 ± 6 (p=0.0425) and 30 ± 2 
(p=0.005) derived from Gibco and ES-tested serum, respectively. In terms of the 
number of segregated ES cells and cell viability, cultures supplemented with Hyclone 
serum gave the lowest yields (Figure 3). Besides, cells with relatively abundant and 
irregular cytoplasm were noted in cultures supplemented with Hyclone serum as 
compared to small discoid mononuclear cells with a rim of cytoplasm derived from 
culture supplemented with ES-tested serum (Figure 4). There was also an increase in the 
numbers, of differentiated cells without the expression of the ES cell marker, SSEA-1 in 
culture supplemented with Hyclone serum after two passages (Figure 5). 
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Table 5 Numbers of ES cell colonies derived from three random fields of 1 Ox 
objective in three separate experiments on ES cell D3 in culture medium 
supplemented with three foetal calf sera. 
Number of colonies per 3 x 10^ ES Cells D3 
Experiment ES Hy Gi 
I 28 8 28 
II 32 10 - 18 
III 30 10 19 






Figure 3 Total cell numbers (left axis) and cell viability (right axis) derived from 
three separate experiments on ES cell D3 culture supplemented with three 
different foetal calf serum 
Cell number Viability (%) 
( 1 X 105) 
1 0 ： 1 0 0 
8 - ^ ^ - 80 
- - 6 0 




ES Hy Gi 
‘ serum 
ES: ES-tested serum 
Hy: Hyclone 
Gi: Gibco 
Colour bars: Cell numbers in 10^  
Blue line: Cell viability 
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Figure 4 Morphology of ES cell D3 maintained in cultures supplemented with 
two different foetal calf sera, (a) ES cells showed signs of differentiation 
in the cultures with Hyclone serum. Some ES colonies were flattened and 
surrounded by a circle-like boundary, and appeared as individual cells 
rather than as syncial mass, (b) Some differentiated ES 
colonies had necrotic centers with defined boundaries and edges appear 
dark and irregular, (c) Undifferentiated ES colonies appeared as syncial 
mass. 
^ ^ H y ^ n e ^ 4x o ^ g ^ v e (b) Hyclone; lOx objective 
_溯 
(c) ES-tested; 20x objective 
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Figure 5 Immuno-staining of SSEA-1 on ES cell D3 maintained in cultures 
supplemented with three different foetal calf sera after two passages. ES 
cells harvested from the three different cultures showed SSEA-1 
expression (a-c; green fluorescent), with cells from ES-tested serum (a) 
showing a stronger intensity than that of Hyclone serum (b). The results 
also show that undifferentiated mouse ES cells have a large nucleus to 
cytoplasm ratio as shown in (c). These slides were counter-stained with 
PI to show the nuclear structures. 
_ 
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Data of this evaluation suggested that there might be less growth-promoting 
factors to ES cells in Hyclone serum. There were also likely toxic substances and 
differentiating agents to inhibit propagation and enhance differentiation of ES cells, 
respectively. In subsequent downstream analyses employing serum-based medium, ES-
tested serum was used. 
4.1.2 Feeder effect 
Primary cultures and established cell lines of mouse embryonic fibroblasts 
producing LIF play a crucial in the propagation of mouse ES cells in-vitro (O'Shea 
2004). Table 6 shows the numbers of SSEA-1+ ES colonies D3 maintained on chamber 
slides pre-established with and without PMEF in three separate experiments. The 
percentage of SSEA-1+ colonies derived from PMEF support was significantly higher 
than that without feeder (91.0% 士 3.6o/o vs. 80.0% 士 4.4o/o, p=0.032). In terms of the 
number of SSEA-1+ ES colonies, cultures with and without PMEF yielded a comparable 
-number of ES cell colonies (Figure 6). However, the percentage of SSEA-1+colonies 
were higher in cultures with than without PMEF support (p=0.030). Data suggest that 
PMEF could help maintain the ES cell sternness from differentiation. 
The efficacy of mouse embryonic fibroblasts derived from either primary 
cultures or established cell line in ES cell maintenance was also evaluated. Figure 7 
shows tHe total numbers of ES cells D3 and the extents of cell viability in two 
consequent passages in three separate experiments using chamber slides. Both PMEF 
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and STO supported the growth of undifferentiated ES cells D3 and the extents of cell 
viability were above 95% 士 3o/o. From the average of three separate experiment, ES 
cells D3 maintained on PMEF propagated at significantly higher rates as compared to 
those derived from STO in two consequent passages (first passage in two days: fold 
increase of cell numbers in PMEF vs. STO: 4.7 士 0.29 vs. 3.0 士 0.31，p=0.001; second 
passage in one day: 5.5 士 0.28 vs. 3.8 士 0.14，p=0.012). The sternness of ES cells D3 
maintained on PMEF and STO was also evaluated. A comparatively higher number of 
SSEA-1 + cells was noted in ES cell cultures maintained on PMEF (PMEF vs. STO: 92.1 
士 4.2o/o vs. 83.3 士 2.9o/o, p=0.029) as shown in Figure 8. Having replated onto tissue 
culture dishes for 45 minutes to get rid of PMEF, enriched ES cells D3 derived from the 
second passage were immuno-stained for SSEA-1 (Figure 9). Data on the cell number, 
viability and SSEA-1 immuno-positivity suggested that PMEF was superior to the 
mouse embryonic fibroblast cell line STO in the propagation and maintenance of ES 
cells. 
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Table 6 Number and percentage of SSEA-1+ ES colonies in three separate 
maintenance cultures of ES cell D3 with and without feeder support of 
primary mouse embryonic fibroblasts in chamber slides. 
Mean number and Percentage of SSEA1+ ES colonies 
Experiment With PMEF Without PMEF 
I 252 (87) 317(78) 
II 242 (94) 304 (85) 
III 264 (92) 299 (77) 
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Figure 6 Comparisons of SSEA-1 positivity and number of colonies of ES cells 
D3 propagated and maintained with or without PMEF. 
Number of 
SSEAl SSEA1 + 
Positvity (%) colonies 
100 - I 1000 
- 800 
90 . 
丄 - 6 0 0 
- 4 0 0 
- 200 
70 -I ‘ — — ^ — — 0 
With PMEF Without PMEF 
Colored bars: SSEA-1 positivity 
Blue line: colony number 
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Figure 7 Total number of ES cells D3 and cell viability in two consecutive 
passages derived from PMEF and STO support (as shown) on chamber 
slides in three separate experiments. 




T T - 100 
遷 
0 1st 2nd 
Passage 
• Cell number: D3 on MEF 
• Cell number: D3 on STO 
Viability: D3 on MEF 
寺 Viability: D3 on STO 
83 
Figure 8 The extent of sternness in terms of SSEA-1 immuno-positivity of ES 
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In the propagation of ES cells using feeder cell support, there was a nominal number of 
residual inactivated feeder cells, despite the ES cell product was re-plated onto tissue 
culture dishes for 45 minutes. They could easily be distinguished from undifferentiated 
ES cells under microscope. ‘ 
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Figure 9 SSEA-1 immuno-reactivity of ES cells D3 maintained on PMEF and 
passaged twice. Almost all D3 were SSEA-1+. The majority of PMEF 
(SSEA-T) were removed by their adherent property. A very small portion 
of differentiated ES cells would still show SSEA-1-positivity, which was 
characterized by a relatively small nucleus (white circle in (b))，when 
compared with undifferentiated ES cells'. 
•
(b) 60x magnification 
•
(d) STO negative control 
• 
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4.1.3 Serum-free and feeder-free condition 
Pertaining to the constraint of quality serum and synchronization of feeder cell 
culture in the propagation of ES cells, a protocol employing serum-free and feeder-free 
culture condition would be advantageous. ES cells D3 were seeded separately onto low 
binding flasks, ultra-low adherent plates and bacterial Petri dishes, of serum-free culture 
medium at 1 x 10^ per mL. Non-adherent cell clusters of variable sizes and irregular 
contour were noted after two days, which accounted for more than 90% of the culture 
(Figure 10). Some have sprouting processes indicating signs of differentiation. Cultures 
were split and propagated in fresh medium for further two days. Figure 11 shows data 
of three separate experiments. The SSEA-1 reactivity of the first passage on day 2 was 
82.6% 士 5.70/0，whereas SSEA-1+ cells of the second passage on day 4 decreased 
significantly to 63.7% 士 5.0o/o (p=0.001), which were far less than those maintained in 
serum-based medium with PMEF support (p=0.009). 
» � 
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Figure 10 Non-adherent cell clusters of ES cells D3. Variable sizes and irregular 
contour were observed from serum-free and feeder-free cultures for two 
days. Process sprouting was evident in some cell clusters. 
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Figure 11 Immuno-reactivity of SSEA-1 in ES cells D3 propagated in serum-free 
medium without feeder support on non-adherent culture wares. Data 
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4.1.4 Overall effect 
The optimized culture condition on ES cells D3 was attested on ES cell line, 
E14TG2a, The propagation medium supplemented ES-tested serum in conjunction with 
PMEF feeder support worked equally well in propagating E14TG2a without any 
sacrifice of the sternness. Figure 12 shows that they were morphologically 
undifferentiated and immunologically positive to SSEA-1, Oct-4 and Tral-81, which are 
markers of undifferentiated ES cells, suggesting the applicability in the propagation and 
maintenance of ES cells. 
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Figure 12 Immuno-staining of Tral-81, Oct-4 in ES cells D3 and E14TG2a 
maintained on PMEF in serum-based propagation medium for two 
days. ES cells formed colonies on PMEF, and they are immuno-positive 
with Tral-81 and Oct-4 (green fluorescent counter-stained with PI), (a-b) 
E14TG2a on PMEF, (c-d) D3 on PMEF. (a) and (c) were observed under 
fluorescent microscopy, (b) and (d) were observed under phase-contrast 
microscopy and background showed PMEF. 
(a) Tral-81 ^ 
mm 




4.2 ES cell Induction 
4.2.1 Retinoic acid 
Table 7 shows viabilities of three separate experiments employing 0.5 mM RA in 
the differentiation of ES cells D3. Upon induction for eight days, the mean proportion 士 
one standard deviation of cell viability of trypsinized cells derived from RA-mediated 
differentiation culture was 81.5% 土 2.5o/o, being significantly lower than 88.3% 士 2.5o/o 
of the controls (p=0.046). Besides, RA-induced cells displayed morphologies of neural 
cell lineage with sprouting processes and networks with neighbouring cell foci (Figure 
13). Immunohistocliemistry demonstrated the immature neuronal marker of TuJ-III, 
NSC marker of nestin, astroglial marker of GFAP and oligodendroglial marker of MBP 
(Figure 14). The mean percentage of immuno-positive cells were shown in the Table 8. 
Among TuJ-III+cells, the majority gave little to no immuno-reactivity with, the marker 
of matured neurons antibodies, MAP-2, suggesting that the presence of immature 
neurons. 
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Table 7 Cell viability of ES cell-derived EB in three separate experiments. 
Cell Viability in Percentage 
Retinoic Acid With Without 
I 78.8 88.0 
II 82.0 86.0 
III 83.7 91.0 
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Figure 13 Morphology of retinoic acid-induced neural cell lineage from D3 
observed under phase contrast microscopy. They formed network with 
neighbouring cell foci. 
(a) lOOx magnification 
_ 
‘ "(b) 60x magnification 
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(c) 40x magnification 
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Figure 14 Immuno-reactivity of RA-induced cell product showing morphology of 
neural cell lineage, (a) neural stem cell marker nestin (green fluorescent), 
(b-d) immature neuronal marker TuJ-III (green fluorescent), at lOOx 
magnification under fluorescence microscopy. TuJ-Iir formed network 
with neighbouring cells. These slides were counter-stained with PI to 
show the nuclear structure. 
•




Table 8 Proportion of neural cell lineage commitment of RA-induced cell product. 
Percentage of Positivity 
Marker (Lineage) RA Control 
TuJ III (Neurons) 39 3 
Nestin (Neural Stem Cells) 29.5 >1 
GFAP (Astrocytes) >1 >1 
MBP (Oligodendrocytes) >1 >1 
ii 
95 
4.2.2 Stromal cell-derived inducing activity 
4.2.2.1 Molecular characterization of candidate stromal cells 
The potential applicability of C17.2, L and L-Wnt-3A as feeder layers in exerting 
SDIA for ES cell derivation into neural cell lineage were examined by RT PCR for gene 
transcripts of neurotrophins, growth factors and chemokines. Figure 15 illustrates that 
C17.2, L and L-Wnt-3A cell lines expressed neurotrophins of BDNF, NT-3, NGF, 
GDNF’ CNTF and IGF-1 & 2. The feeders also expressed bFGF, which is well-known 
growth-promoting factor for NSC. Besides, neural inducing factors of VEGF and EPO, 
which were noted to promote neural differentiation, were also detected in these feeder 
cells. Chemokine (C-X-C motif) CXCL-12 and Wnt-SA were only detected in the neural 
precursor cell line C17.2 and the virally transfected L-Wnt-3A cells, respectively. Data 
derived from molecular analyses suggested that these cell lines may be candidate 
stromas to mediate SDIA for neural differentiation of ES cells. 
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Figure 15 Ethidium bromide-stained agarose gel of electrophoresed RT-PCR 
products namely, NT-3，BDNF, GDNF, CNTF, IGF-1’ IGF-2, NGF’ 
bFGF, EPO, VEGF, CXCL-12 and Wnt-3A, derived from neural 
precursor cells CI7.2, L cells and L-Wnt-3A cells. 
r o . r n ^ r n ^ r n 
r > ^ eg g r > ^ tg S r > k) (S S r > S tg g 
^wmwmmi 
NT-3 BDNF GDNF CNTF 
bFGF IGF-1 IGF-2 NGF 
CXCL12 Wnt-3A EPO VEGF 
Pos: positive control ‘ 
Neg: negative control 
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4.2.2.2 Direct contact co-culture 
Discrete ES cells, D3 and E14TG2a, were seeded separately onto pre-established 
mitomycin C-inactivated feeders, CI7.2，L, L-Wnt-3A and cultured for eight days. 
Some were differentiated and became morphologically indistinguishable from the 
feeders (Figure 16). Despite attempts of extensive inactivation to the stromal cells using 
prolonged mitomycin C treatment or y-irradiation, isolation of SDIA-induced cell 
products were difficult. 
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Figure 16 Nucleation of growing cell foci of ES cells D3 seeded onto stromas 
(co-cultured for eight days), (a) D3 with CI7.2 and (b) D3 with L 
under phase contrast microscopy, (c) D3 with CI7.2 and (d) with L cells. 
(a) with C17.2 (40x) (b) with L (40x) 
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4.2.2.3 Non-contact co-culture 
Non-contact co-culture allows free diffusion of bio-metabolites and soluble 
factors among cells of interest separately grown in two compartments: cell inserts of 
finely pored permeable membrane on wells of culture plates (Figure 17). The SDIA of 
C17.2, L-Wnt-3A and L cells were evaluated by seeding ES cells D3 and E14TG2a onto 
poly-L-omithine- and laminin-coated wells and co-culturing with confluent growth of 
mitotically inactivated stromal cells pre-established on cell inserts for eight days. Cross-
talks of cell foci with protruding processes were evident in co-cultures of ES cells D3 
and neural precursor cells CI 7.2, whereas colonies of undefined contours in a flat sea of 
small round cells were also present (Figure 18). In-situ immuno-staining demonstrated 
the positivity of the NSC marker, nestin, in more than 60% of cell foci in all co-cultures 
(Figure 19). 
Figure 20 showed the percentages and numbers of nestin+ cell foci derived from 
‘co-cul tures of ES cells D3 and the three stromal supports in four separate experiments. 
All SDIA-induced cultures yielded a significantly greater number of nestin+ colonies as 
compared to 54.9% in control cultures without SDIA (CI7.2 cells: 74.7%, p = 0.029; L 
cells: 64.9%, p = 0.029; L-Wnt-3A: 64.7%, p = 0.029). Among the three stromas, C17.2 
displayed the strongest inducing activity on the generation of nestin+ colonies, which 
was significantly superior to the two counterparts (p = 0.029). Conversely, the numbers 
of nestin+ colonies derived from co-cultures with L cells and L-Wnt-3A cells were 
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comparable (p = 1.000)，suggesting that Wnt-3A protein may play a little role in ES cell 
derivation into neural cell lineage. 
The SDIA of C17.2 cells, L cells and L-Wnt-3A cells were attested on the other 
cell line E14TG2a in four separate experiments (Figure 21). Similar readouts were 
obtained. The proportions of nestin+ colonies derived from the three stromas were 
74.8%, 70.1%, and 68.6%, respectively, being significantly greater than 57.2% in 
control cultures without SDIA (C17.2 cells: p=0.029; L cells: p = 0.029; L-Wnt-3A cells: 
p = 0.029). Despite SDIA derived from CI7.2 cells was noted to yield the highest 
number of nestin+ colonies in the induction of ES cells E14TG2a, the extent did not 
reach a statistical significance as compared to those of L cells and，L-Wnt-3A cells 
(C17.2 vs. L cells: p = 0.343; C17.2 vs. L-Wnt-3A: p = 0.343). The comparable 
numbers of nestin+ cell foci derived from co-cultures of ES cells E14TG2a and L 
cells/L-Wnt-3A cells supported the notion that Wnt-3A protein may not be crucial in the 
induction of ES cells into neural cell lineage. 
Cell products derived from SDIA-induced cultures of ES cells D3 and E14TG2a 
on CI7.2 cells were molecularly characterized for lineage commitment by using RT-
PCR (Figure 22). They were noted to express neural cell lineage-related genes: Pax6 
and Otxl (neuro-ectodermal), Nurrl (neuronal) and GFAP (astroglial). CXCR4 which 
is the ligand of the chemokine SD¥-\/CXCL-J2 was also detected in the cell product 
indicating cues on the migration of NSC in the CNS. Brachyury and a-fetoprotein 
which are genetic markers of mesodermal and endodermal cells, respectively, were not 
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amplified in the cell products suggesting relatively pure populations of neural cell 
lineage being free of any mesodermal and endodermal cells. However, weak expression 
of Oct-4 was noted implying residual ES cells in the cell products. 
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Figure 17 Non-contact co-culture system. This is basically consisted of cell inserts 
(arrow) with permeable membrane hung over the tissue culture plate. 
The whole apparatus allows freely diffusible biometabolites across the 




Figure 18 Cell foci derived from non-contact co-cultures of D3 for eight days. In 
CI 7.2 stroma, some cells formed network with neighbouring foci, as red 
arrows in (a) and (b). In L (c) or L-Wnt-3A (d), most colonies had 
undefined contours and small round cells were observed in the 
background. 
(a) D3 and CI7.2; 40x magnification ( b )匹a n d C17.2; 60x 
I f , r^L [ i 





Figure 19 In-situ nestin staining of cell colonies derived from non-contact 
co-cultures of ES cells D3 and CI7.2. (a) phase contrast image of cell 
focus, (b) nestin+ focus (green fluorescent, counter-stained with PI) and 




Figure 20 Proportion and number of nestin+ cell foci derived from four separate 
experiments in non-contact co-cultures of ES cells D3 and stromal cells, 
CI7.2, L，and L-Wnt-3A. 
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Figure 21 Proportion and number of nestin+ cell foci derived from four separate 
experiments in non-contact co-cultures of ES cells E14TG2a and stromal 
cells, CI7.2, L, and L-Wnt-3A. 
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Blue line: number of positive cell foci 
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Figure 22 Ethidium bromide-stained agarose gel of electrophoresed RT-PCR 
products of SDIA-induced cell products. (Pax6, Otxl: neuroectodermal 
markers; Nurrl: neuronal marker; GFAP: astroglial marker; nestin: neural 
stem cell marker, CXCR4, a chemokine receptor; Oct-4: ES cells 
marker; Brachyury: mesodermal marker; AFP: endodermal marker; 
GAPDH: a house keeping gene) 
Otxl Nurrl 
Pax6 
^ ^ ^ 
nestin G F A P ^ ^ ^ ^ H 
GAPDH 
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4.2.2.4 Cultures in CM 
Spent media of four-day cultures of confluent growth of irradiated C17.2 cells, L 
cells and L-Wnt-3A cells were collected on every two alternate days. Collections from 
six batches were pooled and used as the CM. The viability of 1 x 10^ ES cells D3 
cultured in wells of serially diluted C17.2-derived CM for four days showed that half-
diluted CM could best support cell growth pertaining to the likely endogenous growth-
promoting factors and inhibitory bio-metabolites or toxins being diluted to an optimal 
titrate (Figure 23). Besides, neural induction was also evident as shown in Figure 24. 
In the comparative study of the efficacy of three CM, readouts in a similar 
pattern were noted in the induction of ES cells D3 and E14TG2a in three separate 
experiments (Figures 25 and 26). The mean proportions of nestin+ cell foci of ES cells 
D3 cultured in CM derived from CI7.2 cells, L cells and L-Wnt-3A cells were 69.7%, 
61.8% and 61.6 %, respectively, being greater than 55.2% in the controls using no CM, 
but not statistically significant (CI7.2 cell-derived CM: p = 0.1; L cell-derived CM: 
p=0.2; L-Wnt-3A cell-derived CM: p=0.2). So did the percentages of nestin+ colonies 
derived from ES cell E14TG2a cultures in three CM as compared to 54% in the control 
cultures without CM (C17.2-derived CM: 72.6%, p=0.1; L cell-derived CM: 63.7%, p = 
0.2; L-Wnt-3A cell-derived CM: 69.2%, p = 0.1). 
The incidences of nestin+ cell foci of ES cells, D3 and E14TG2a, cultured in L 
cell- and L-Wnt-3A cell-derived CM were comparable (D3: p = 1.000; E14TG2a: 
109 
p=0.400). However, the number of nestin+ cell foci derived from ES cells D3 and 
E14TG2a were significantly greater in CM of L-Wnt-3A cells than CM of L cells (L-
Wnt-3A cell-derived CM vs. L cell-derived CM: D3: 117 士 10.5 vs. 80 士 2.1; p = 0.013; 
E14TG2a: 60 士 4.4 vs. 30 土 4.7; p = 0.008), suggesting the growth-promoting role of 
Wnt-3A. 
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Figure 23 Mean cell viability and number of 1 x 10^  ES cells D3 cultured for four 
days in wells of the C17.2-derived CM at various concentrations in three 
separate experiments. 
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Figure 24 Morphology and in-situ immunostaining for nestin of cell foci from 
cultures of ES cells D3 in C17.2-derived CM for eight days, (a) phase 
contrast image, (b) a nestin+ colony (green fluorescent, counter-stained 
with PI) with extensive protruding processes, and (c) a brightly positive 
colony with radial processes. Arrows are pointing to the radial processes, 




Figure 25 Proportion and number of nestin+ cell foci derived from cultures of ES 
cells D3 in conditioned media prepared from CI7.2 cells, L cells and L-
Wnt-3A cells in three separate experiments. 
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Figure 26 Proportion and number of nestin+ cell foci derived from cultures of ES 
cells E14TG2a in conditioned media prepared from C17.2 cells, L cells 
and L-Wnt-3A cells in three separate experiments. 
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4.3. ES cell Differentiation 
C17.2-mediated SDIA-induced cell products of ES cells D3 were enzymatically 
segregated using trypsin and 2 x 10^ discrete cells in 2 mL serum-free N2B27 medium, 
without any supplement of growth factors or cytokines, were seeded in triplicate onto 
poly-L-omithine- and laminin-coated coverslips in wells of 24-well culture plates. 
Cultures were maintained for 10 days with changes of the induction medium III (N2B27) 
medium fpr every alternate day. In-situ immuno-staining showed that the differentiated 
cell products expressed the neuronal markers of TuJ-III and MAP-2, DA neuron marker 
of TH, astrocytic marker of GFAP and oligodendrocytic marker of MBP. The immuno-
positive cells existed as single cells, clusters and sheets (Figure 27). Microscopic 
examination of five randomly selected fields of lOx objective revealed that the mean 
percentages 土 one standard deviation of tubulin^ cells, MAP-2+ cells, TH+ cells, GFAP+ 
" . � c e l l s and MBP+ cells were 28% 士 lO。/。，20% 土 IQo/o，12% 士 4o/o, 5% 土 4 � / � a n d 12% 士 
7%, respectively, suggesting that ES cells could be induced and differentiated into 
neural cell lineage through the SDIA of the neural precursor cell line CI 7.2. 
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Figure 27 In-situ immuno-staining of SDIA-induced cell product of ES cells D3. (a) 
MBP-expressing oligodendrocytes, (b) GFAP-positive astrocytes, (c) 
immature TuJ-III+ and (d) mature MAP2+ neurons, and probably (e) TH+ 
dopaminergic neurons, were observed in N2B27 medium for further 10 
days. All markers are green fluorescent and slides were counter-stained 
with PI to show the nuclear structure. 
(a) MBP (b) GFAP 
• • 
(c) TuJ III (d) MAP-2 • • 
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4.4 In vivo study of ES cell-derived cell products 
4.4.1 Animal preparation 
Twenty-four adult male ICR mice of mean age 12 weeks were divided into three 
arms at random namely, normal control group, ischaemic group and transplanted group. 
Global cerebral ischaemia was induced to 18 mice a week prior to cell implantation 
(Figure 28). The operated animals exhibited signs of disturbance of consciousness 
including drowsiness, paucity of movement and even coma which was evident in a 
mouse. Having undergone transient BCCAO, 12 mice survived accounting to the 
survival rate of 66.7%. 
4.4.2 Cell preparation 
One day in advance of the transplantation, SDIA-induced and differentiated cell 
. p r o d u c t s of ES cells D3 co-cultured with CI7.2 were labeled with BrdU. Trypan blue 
dye exclusion test and immuno-staining of the BrdU-labelled cell products illustrated 
74% viable cells and 75% nestin+ cell foci, respectively. 
4.4.3 Cell implantation 
Having been mechanically dislodged from the culture wares, five i^L of 5 x 10^ 
viable SDIA-induced and differentiated cell products of ES cells D3 were implanted 
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onto the mouse striatum, at the pre-determined stereotaxic co-ordinates, of transplanted 
group (Figure 29). 
» � 
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Figure 28 Global cerebral ischaemia induced by transient BCCAO for 15 minutes. 
Picture (a) showing that two micro-aneurysm clips were placed over the 
bilateral common carotid arteries in the neck, (b) A magnified view of the 
occlusion region illustrating that blood was blocked from flowing from 
the lower part of the body to the brain. 
^ — — ^ 
micro-aneurysm I w 
^ ^ ^ ^ ^ H p v ^ w B Left common 
^ ^ ^ ^ ^ B ^ f e ^ ^ ^ ' ^ B a h B L ^ carotid artery 
- ^^^^Hi’ mm.丨 
^ ^ ^ ； : 
pff^ .__•K-SI^ L ‘ 
(b) • 
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Figure 29 Neuro-surgical procedure of cell transplantation, (a) An ischaemic mouse 
was sedated and immobilized onto the stereotaxic apparatus, (b) ES 
cell D3-derived cell product was implanted intracranially onto the 
straitum by a Hamilton syringe through a hole drilled at the pre-
determined co-ordinates. 
I H 
H ^ l . ^ H o l e d r m e d ^ - — ^ . I ^ H 
at predetermined coordinates 
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4.4.4 Behaviour Monitoring 
Two weeks post-implantation, the spatial learning and memory ability of mice of 
interest were assessed using the water maze system (Figure 30). Upon completion of 
daily training on three occasions, the number of episodes for mice entering cue de sacs 
and the time taken to find the way out during the manoeuvre on the following two days 
were reckoned. Figure 31 shows that the incidences of error committed by mice among 
the three studied arms on day four and day five were comparable. Figure 32 illustrates 
the time taken by ischaemic mice to go through the maze were relatively stable over five 
days. On the contrary, there was a progressive reduction of travelling time spent by both 
normal mice and ischaemic mice having undergone ES cell-derived cell therapy. 
Basically, both normal control mice and cell therapy-treated ischaemic mice could find 
their way out in less than a minute on day five, which were significantly shorter than that 
taken by the ischaemic counterparts (mean value in second: cell therapy-treated 
ischaemic group vs. ischaemic group: 43 vs. 161, p=0.008, n=12; normal control group 
- , vs. ischaemic group: 56 vs. 161, p=0.009, n=12). 
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Figure 30 The water maze system for testing the spatial learning and memory 
ability of mice, (a) The overall view of the system, (b) a test mouse swam 
shortly away from the start point in the far left of the maze, (c) a test 
mouse negotiated its way out of a cue de sac, (d) a test mouse eventually 
made it and climbed up the ladder at the finishing spot. 
� : (b) 




Figure 31 The average number of errors, in terms of entering cue de sacs of the 
water maze system, committed by the tested mice (six each in three 
studied arms on five consecutive days). Control group are normal mice. 
Ischaemic (IS) group and transplanted ischaemic (IS+C) group are 
mice injected intracranially with normal saline and ES cell-derived cell 
product, respectively, two weeks post-induction of global cerebral 
ischaemia. 
Error Incidences 
1 2 3 4 5 
Day 
— n o r m a l 
-m-lS 
IS + C 
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Figure 32 The average time taken to find the way out and climb up the ladder at 
the finishing spot by the tested mice (six each in three studied arms on 
five consecutive days). Control group are normal mice. Ischaemic (IS) 
group and transplanted ischaemic (IS+C) group are mice injected 
intracranially with normal saline and ES cell-derived cell product, 
respectively, two weeks post-induction of global cerebral ischaemia. 
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240 
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4.4.5 Histology of cell-implanted brain 
Shortly after behavioral assessment mice were euthanized and ？ra«5-cardiacally 
perfused to strip off peripheral blood. Heads were decapitated and the whole brains 
were removed from the skulls for histological evidence of implantation of ES cell-
derived cell product. 
Figure 33 shows that BrdU-labelled ES-derived cell products predominantly 
localized along the needle track of injection in the brain with minor degree of cell 
migration to the vicinity. Meticulous examination of brain tissues contralateral to the 
site of injection revealed scanty BrdU+ cells (Figure 34)，suggesting a small number of 
cells are migrating from injection site contralaterally. 
Haematoxylin and eosin staining of the coronal sections of brain tissues 
illustrated one of the six transplanted mice had teratomatous component and produced 
•“ .� teratomas, included ciliary epithelium (endoderm), cartilage and stromas (mesoderm), 
and squamous epithelium (ectoderm) (Figure 35). 
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Figure 33 Immuno-staining of coronal sections of brain tissues three weeks post cell 
implantation using FITC-conjugated anti-BrdU labeling (green 
fluorescent). BrdU+ cells are mainly localized in the injection site, and 




Figure 34 Immunostaining of coronal sections of brain tissues three weeks post cell 
implantation using FITC-conjugated anti-BrdU labelling (green 
fluorescent). Results provide evidence on some degree of migration of a 
small quantity of grafted cells contralaterally, as shown by the white 
arrows. 
^a}J^?UTmgnification (b) 1 OOx magnification 
• 
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Figure 35 Haematoxylin and eosin staining of coronal sections of the mouse brain 
tissue three weeks after intracranial implantation of ES cell D3-derived 
cell product. Teratomas in one of the transplanted mice (a) showing 




Chapter 5 Discussion 
The discovery of stem cells has triggered high expectations, from both the 
scientific and medical arenas to the general public at large, as a novel treatment modality 
for neural diseases and disorders pertaining to either cell loss or degeneration, which 
current medical and neuro-surgical interventions deliver little therapeutic efficacy to 
survivors harassed with long-term to permanent neurological deficits (Svendsen et al. 
1999; Gepstein 2002; Haas et al. 2005). Basically, ES cells, which are derived from an 
embryonic cell population at a stage prior to any lineage commitment to particular 
tissues of the body, are by nature more primitive and versatile than their adult 
counterparts. The availability of rodent-, primate- and human-derived ES cell lines 
helps manipulate ES cell cultures in-vitro and produce high yields of differentiated cells 
of neural lineage in large numbers for pre-clinical studies in disease models prior to 
clinical trials. 
‘ There is a plethora of reports in the literature describing the maintenance, 
induction and differentiation of ES cells using different methods and procedures 
employing chemical stimulants, growth factors, signalling molecules and regulators, 
inducing factors and/or genetic manipulation. Apparently, all these manoeuvres were 
executed to simulate the in-vivo developmental microenvironments of ES cells and 
lineage-restricted precursors and end-stage mature cells of interest. The efficacy varies 
in terms of yield, purity, viability and functionality, not to mention the ease of 
performance and processing time required. 
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ES cell maintenance is a very important process to propagate them in-vitro in the 
way that the sternness of the progenies is identical to that of their predecessors without 
any differentiation. It secures the provision of quality yield of undifferentiated ES cells 
for down-stream experiments. However, ES cells are very vulnerable to the in-vitro 
conditions of propagation. A slight variation may result to undue differentiation (Pollard 
1997; Marshak 2001). 
ES cells are normally propagated by co-culturing with mitotically inactivated 
PMEF or mouse embryonic fibroblast cell lines in serum-based medium supplemented 
with LIF. In mouse ES cells, LIF plays a crucial role in preventing differentiation by 
activating the LIF-STAT3 signalling pathway involved in the in-vitro self-renewal 
process (Williams et al. 1988; Gough et al. 1989; Yoshida et al. 1994; O'Shea 2004; 
Cartwright et al. 2005). That LIF was detected in cultures of PMEF and the mouse 
embryonic fibroblast cell line STO was reported (Smith et al. 1987; Smith et al. 1988). 
" . It is suggestive that LIF and other uncharacterized anti-differentiating factors derived 
from PMEF and STO may help prevent ES cell differentiation (Lim et al. 2002). Data of 
this study showed that STO was less efficient than PMEF in preventing ES cell 
differentiation as shown by the comparatively higher numbers of SSEA-l" cells in the 
maintenance cultures of ES cells on STO support. It has been reported that anti-
differentiating effect of feeders could progressively diminish and be lost upon 
continuously multiple passages (Williams et al. 1988; Joyner 1999). The observation in 
this study provides a note of caution in assuming the sternness of ES cells maintained on 
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STO of an unknown passage number. 
The nature of serum in the culture medium plays a pivotal role of ES cell 
maintenance. There are many uncharacterized bio-metabolites, factors, substances and 
molecules, either growth-promoting or growth-inhibiting, which vary significantly from 
lots, batches and manufactures (Ward et al. 2002). It was evident in this study that ES 
cell maintenance cultures supplemented with un-tested serum displayed a slower 
propagation rate and even signs of differentiation. Optimally screened serum is 
mandatory to maintain ES cells and avoid differentiation. 
Propagation of ES cells in serum-free condition was advocated (Ward et al. 2002; 
Cheng et al. 2004). In this study, an alternative approach was used to propagate ES cells 
in suspension cultures by employing the chemically reconstituted serum-replacer (SR) in 
lieu of serum and feeder support on low adherent culture wares to prevent spontaneous 
differentiation mediated by cell adhesion. The extents of proliferation and sternness of 
first few passages of ES cells propagated in serum-free condition were comparable to 
those derived from serum-based cultures on feeder support. However, SSEA-1 immuno-
reactivity decreased progressively in subsequent ES cell passages suggesting the 
insufficiency of serum-replacer in maintaining ES cell integrity and the importance of 
feeder support to augment LIF to prevent spontaneous differentiation of ES cells. Data 
of this study were in contrast to that of Christopher and co-workers (Ward et al. 2002). 
The observation may be attributable to the density of seeded cell and the nature of 
culture. In their study, a relatively high density of ES cells, 3 x 10^/ml was seeded in a 
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100mm dish. ES cell ES cell lines were weaned by subsequent passaging in media of 
serially increased SR percentage (FCS/SR: 75/25%, 50/50%, 25/75%, and 0/100%) 
before removal of feeders. Besides, the ES cells were cultured on gelatinized dish, 
instead of suspension culture. However, the proportion of ES cells derived from serum-
free condition expressing ES cell-specific markers of Oct-4 and SSEA-1 were not 
studied. 
Throughout the project, ES cell lines, D3 and E14TG2a, were propagated on 
mitotically inactivated PMEF in propagation medium supplemented tested serum and 
LIF. The medium was changed at least once daily. 
In the CNS there are many neurons, however glia including astrocytes, 
oligodendrocytes, ependymal cells and microglia outnumber neurons by ten-fold and 
their precise roles and functions in the CNS have not yet been fully elucidated. They are 
considered to be sleeping giants with immense and enormous potentials. Apart from 
" .. synthesizing neuro-transmitters, neurotrophins, growth factors, cytokines, adhesion 
molecules, the respective receptors and ligands are regulating the contents in their extra-
cellular territories, glia are also noted in enveloping synaptic junctions, myelinating and 
insulating axons, providing linings of fluid-filled ventricles, directing cell migration and 
phagocytosing debris left by dead or degenerating neurons and glia (Siegel 1999). They 
play an indispensable role in neural tissue repair and regeneration in the CNS system, 
which effects may be attributable to the SDIA. 
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Neural induction of mouse ES cells by SDIA of the stromal cell PA6 derived 
from skull bone marrow was first reported by Kawasaki and co-workers in Japan 
(Kawasaki et al. 2000). It was noted that PA6-derived SDIA could induce efficient 
neuronal differentiation of co-cultured ES cells in serum-free conditions without use of 
either RA or EB. The effects are likely attributed to the production of neural cell-
inducing factors in both labile soluble and cell surface-anchored forms or the secretion 
of factors secondarily tethered to the ES cell surface, which then elicit neural 
differentiation (Kawasaki et al. 2000; Kawasaki et al. 2002; Morizane et al. 2002). 
The molecular basis of induction remains to be understood. It was reported that 
the mesoderm-differentiating BMP-4 suppressed SDIA-induced neuralization and 
promotes epidermal differentiation, suggesting that SDIA acts by stabilizing the 
ectodermal fate and protecting ES cells from mesodermalizing influences (Tropepe et al. 
2001). However, the scenario brings forth the platform of employing stromal support 
mimicking the micro environment of developing or injured brain for induction of ES 
" .. cells into neural cell lineage. ES cells will first be induced to the ectodermal 
commitment using SDIA. They are then allowed to adopt a default differentiation to 
neural fate, be expanded and selected in in-vitro cultures. 
RT-PCR was performed to characterize the neural-lineage related gene 
expression of the neural progenitor cell line C17.2, L cells and the L-Wnt-3A secreting 
biologically active Wnt-3A proteins. Gene expressions of neurotrophic and neutron-
protective factors {BDNF, GDNF, CNTF, NGF, NT-3, IGF-l, IGF-2 and EPO), the 
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angiogenic cytokine VEGF, the chemokine CXCL-12 and proliferative factors of bFGF 
and Wnt-3A were evident in both the intact and mitotically inactivated cultures, 
indicating that these neurotrophins and neural inducers persisted irrespective of drastic 
manipulation in-vitro. 
BDNF have a direct relationship with neurogenesis in response to exercise, 
learning and memory (Berchtold et al. 2005). They are involved in the formation of 
motor neurons (Serpe et al. 2005). GDNF promotes motor axon growth and elicits 
neuro-protective effects (Bohn 2004; lannotti et al. 2004). The exposure to CNTF 
triggers embryonic rat neuro-epithelium and foetal human brain-derived stem cells to 
differentiate into astrocytes and oligodendrocytes (Johe et al. 1996). NGF enhances the 
transition of neuro-progenitor cells to post-mitotic neurons during brain development 
(Sofroniew et al. 2001; Liu et al. 2002). NT-3 acts on the neuronal precursor cells to 
promote the survival and differentiation (Chalazonitis 2004) and expands the density and 
diversity of sensory and motor axon (Lu et al. 2003). IGF-1 which is highly expressed 
"” within the brain is essential for normal brain development. It promotes projections of 
neuron growth, dendritic arborization and synaptogenesis (Bondy and Cheng 2004). 
IGF-2 is shown to exert metabolic activity and neurotrophic activity in-vitro, which has 
been implicated in human brain development (McKelvie et al. 1992). Basic FGF is a 
critical signalling molecule for primitive neural crest cells and is found to facilitate the 
proliferation of NSC (Monsoro-Burq et al. 2003; Itoh et al. 2005). 
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VEGF and EPO are noted to participate in neurogenesis. Studies of foetal and 
postnatal rat cerebral cortical organotypic explants showed that VEGF could cause a 
significant increase in astrocytic proliferation (Mani et al. 2005). Recent studies 
demonstrated that EPO was produced in the brain in response to intrinsic hypoxia which 
enhanced neurogenesis (Wang et al. 2004). Besides, it was reported that neurogenesis of 
the forebrain NSC was regulated by EPO (Shingo et al. 2001). 
CXCL-12 is a chemokine known to exert a regulatory role in NSC migration to 
the site of interest and it acts in an autocrine and a paracrine manner (Tham et al. 2001; 
Stumm et al. 2003). In this study, CXCL-12 expression was evident in the neural 
progenitor cell line CI 7.2，which SDIA of ES cells into neural cell lineage was also most 
remarkable as compared to its two CXCL-12' counterparts, L cells and L-Wnt-3A. 
Perhaps, it is suggestive to a novel function of CXCL-12 in NSC induction, apart from 
the regulatory role in NSC migration. A comprehensive means using microarray 
technology would be beneficial to reveal the prospective factors and study their 
” differential expression in the CNS at different stages of development and disease status. 
Wnt-3A causes the expansion of neural precursor cells in the developing brain 
and spinal cord through the Wnt signalling pathway which has been implicated in the 
expansion of neural precursor cells in the embryo (Shibamoto et al. 1998). The ectopic 
expressions of Wnt-1, Wnt-3A and a constitutive active form of p-catenin which is a 
component of the Wnt signalling pathway, cause the expansion of neural precursor cells 
in the developing brain and spinal cord (Muroyama et al. 2004). Studies on gene 
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disruption indicated that Wnt-1 and Wnt-3A are required for the formation of several 
regions of the CNS including the midbrain, diencephalon, hippocampus, and dorsal 
hindbrain (Shibamoto et al. 1998). One possible explanation for the enlargement of 
precursor population could be an increase in numbers of NSC. The scenario was 
attested in the induction cultures of both ES cells, D3 and E14TG2a, in this study by 
using the CM or co-cultures in the feeder layer secreting Wnt-3A proteins. The absolute 
numbers of nestin+ cell foci derived from co-cultures or CM of L-Wnt-3Acells were 
significantly greater than co-cultures or CM of L cells without Wnt-3A regardless of 
comparable percentages of nestin+ cell foci. 
The molecular characterization of the neurotrophic and neuro-protective factors 
in this study was by no means complete. There are many unknown key factors, 
cytokines, chemokines and adhesion molecules, which may play pivotal roles in ES cell 
induction and be best elucidated by cytokine expression profiling. Nevertheless, the 
expression of this small cohort of neural lineage-related genes in the neural progenitor 
— ... cell line CI7.2, L cells and the L-Wnt-3A is supportive to the hypothesis of SDIA 
derived from these three stromas in the induction of ES cells into neural cell lineage. 
Apart from SDIA, the propagation medium and selection medium also have great 
impacts on the success of neural differentiation. It has been documented that serum 
could strongly inhibit neural differentiation, not to mention the inconsistency of quality 
(Pachemik et al. 2005). Serum-free medium supplemented with fibronectin was used 
throughout the process of induction and differentiation. It was reported that fibronectin 
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enhanced neural differentiation of ES cells and facilitated the growth of NSC without 
impairing their differentiation potential and hindering the generation of specific 
differentiated progeny for cell transplantation (Okabe et al. 1996; Lee et al. 2000; Rappa 
et al. 2004). 
In this study, more than 50% nestin+ colonies were achieved in the control 
cultures without SDIA suggesting a default mechanism available to the neural fate. 
Tropepe and co-workers hypothesized that the neural fate acquisition could be facilitated 
in the absence of non-neural lineage-inducing factors (Tropepe et al. 2001). The 
hypothesis was attested in this study. NSC colonies and neural cell lineage were evident 
after the prolonged in-vitro cultures in expansion medium and selection medium. 
Besides, the number of nestin+ colonies derived from SDIA-induced ES cells was 
greater than that of ES cells without SDIA. It would be attributable to the growth-
promoting effect of bFGF derived from the stromas. 
粉 ,� In this study, it was noted that the effect of SDIA of the neural precursor cell line 
CI7.2 was robust in term of the percentage of nestin+ colonies. The excellence of 
C17.2-derived SDIA may account to both the quantitative and qualitative increase of 
neural cell-related growth-enhancing factors. Apart from NSC, there were mature 
neurons and astrocytes as revealed by RT-PCR for Nurrl and GFAP, respectively. The 
expression of Otxl also suggested the presence of neuro-ectodermal precursors that 
would give rise to the dorsal forebrain. Despite a population of neural cells of different 
phenotypes was evident, SDIA-induced ES cells might differentiate in-vitro using a 
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similar mechanism of CNS development in-vivo. Nestin+ NSC were firstly derived from 
ES cells. With the progressive loss of nestin expression, they differentiated into neural 
progenitors at lower stages of the hierarchy, which Nurrl+, TH+ neurons, GFAP+ 
astrocytes and MBP+ oligodendrocytes emerged. Nonetheless, the yields were relatively 
homogeneous populations of neural cell lineage and were molecularly free of 
mesodermal and endodermal cells. 
Kawasaki and co-workers employed SDIA of PA6 cells on mouse ES cells 
(Kawasaki et al. 2000). They achieved 92% nestin+ cells in contrast to 75% derived 
from CI7.2 cells in this study. Basically, the same notion of utilizing feeder cells 
mimicking the microenvironment of the CNS was employed. PA6 was established from 
skull bone marrow stroma, whereas CI7.2 was generated from neural precursor cells of 
neonatal mouse cerebellum immortalized by transfection of v-myc oncogene. The gene 
knock-in process may upset cytokine production in the neural progenitor cell line in the 
way that some essential growth factors would be lost. The discrepancy in robustness of 
" ,� the SDIA derived from the two cell lines can hardly be ruled out. However, some other 
factors may also account for the difference in efficacy. It was noted that ES cell lines 
differed significantly in the induction and differentiation into cells of interest. The 
Japanese group studied SDIA of PA6 on ES cells CCE and EB5, whereas ES cells D3 
and E14TG2a were induced in this study. Besides, they supplemented culture medium 
with ascorbate, but none was used in this study. An increased level of ascorbate was 
noted during foetal brain development (Kratzing et al. 1985). It was also reported that 
ascorbate could promote neural differentiation in-vitro (Lee et al. 2003). In this study, 
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the effect of SDIA on neural differentiation was examined. The addition of any 
differentiating agent to the cultures would severely mess up the readouts. Irrespective of 
this constraint, it would be promising to incorporate ascorbate into the culture medium 
to augment C17.2-derived SDIA in the differentiation of ES cells into neural cell lineage. 
Apparently, the direct intimate contact of co-cultures of ES cells and feeders 
might not be pivotal in the process of induction, given that feeder cells could still elicit 
SDIA to ES cells in cultures without direct cell-cell interaction. The hypothesis was 
attested using cultures in CM. Readouts of percentages and absolute counts of nestin+ 
colonies derived from ES cell cultures in half-diluted CM were slightly lower than those 
from co-cultures but statistically insignificant. It may be attributable to the functional 
loss of liable growth-promoting factors in the CM which could hardly be preserved. 
Undiluted CM and CM at 75% caused significant cell death and were ineffective to 
support growth pertaining to the accumulation of growth-inhibitory to toxic bio-
metabolites to an intolerable level. 
• � 
Nestin+ NSC instead of maturated neurons were predominant in the ES cell-
derived products. It was reported that fully maturated TH+ neurons survived less 
efficiently than progenitor cells after grafting (Takagi et al. 2005). Besides, their 
integration potential was also lower as Compared to that of NSC upon successful 
engraftment to the injured brain. It would be related to the vulnerability of matured 
neurons to mechanical stress. 
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In the work reported by Elsworth and co-workers, transplantation of 
mesencephalon tissues from embryos at early gestation stage resulted in neurogenesis 
(Elsworth et al. 1996). A better survival of DA neurons in the caudate nucleus of 
Parkinsonian monkeys was evident than neural tissue harvested at later stages. Besides, 
a smaller number of proliferative NSC would be necessitated for therapeutic grafting. 
The pre-requisite of a relatively large number of matured neurons for transplantation 
would be over-ridden (Studer et al. 1998). NSC can be readily induced from ES cells as 
compared to mature neurons. Their plasticity can further allow down-streamed 
differentiation in response to the environmental cues of the recipient brain, which may 
have profound impacts on the survival and fate of the implanted NSC. Xu and co-
worker in China demonstrated that transplantation of NSC to Parkinsonian rats could 
steadily improve the abnormal behaviour in rotation (Xu et al. 2005), suggesting the 
applicabil ity of NSC in cellular therapy. 
In this study, neurons, astrocytes and oligodendrocytes were detected after 10 
— .� days in in-vitro expansion and selection cultures of SDIA-induced cell products in 
serum-free media without cytokine supplement. The time taken in in-vitro 
differentiation of SDIA-induced cell products was in accordance to the time required for 
the in-vivo emergence of neurons in the ventral mesencephalon of mice brain 10 to 12 
dpc during normal development (Kawasaki et al. 2002). It is suggestive that in-vitro 
induced nestin+ cell products would be able to in-vivo differentiate into mature neural 
cells in 14 days. Hence, behavioural assessments were carried out in animals 14 days 
after sham operation or cell therapy. 
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Neither ES cell-derived cell products were electro-physiologically tested using a 
patch-clamp method, nor secretory neurotransmitters was detected 
immunohistochemically in this study. However, they were intracranially implanted onto 
mice with brain ischaemia to evaluate the clinical relevance. There was no sign of 
immuno-rejection. Behavioural tests of ischaemic mice having undergone cell therapy 
demonstrated a significant improvement in spatial learning and memory ability as 
compared to that of ischaemic mice receiving sham operation. Besides, the spatial 
learning and memory ability of transplanted mice and normal control mice were 
comparable. The scenario suggested that functional neural cells could be in-vitro 
derived from ES cells through the SDIA of neural precursor cell line CI7.2 and the 
clinical relevance was noted in ischaemic mice model receiving cell therapy. 
However, the precise mechanisms underlying the clinical relevance remain to be 
established. The grafted cells might integrate to the CNS and directly re-innervated the 
neuronal network of host to induce recovery. Or the neuro-protection and regeneration 
" might be indirectly elicited to the damaged areas of the host CNS through the release of 
a plethora of neurotrophic and neuro-protective agents. Functional improvements might 
often result from cell-mediated self-repair and neuro-protection rather than cell 
replacement (Nakatomi et al. 2002). In this study, the direct and indirect effects of stem 
cell-induced recovery were not determined. 
The cell tracking of transplanted ES cell-derived cell products was made possible 
using in-vitro BrdU labelling, but the process lead to an abnormally low viability of 74%. 
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Although the BrdU labelling efficacy of sphere culture was not determined in this study, 
an average of 68.8% was reported by Takagi and co-workers (Takagi et al. 2005). A 
majority of the donor cells localized along the needle track of injection in the brain and 
the migration of BrdU+ cells was evident in the vicinity. A scanty number of BrdU^ 
cells were observed in brain tissues contralateral to the site of injection, but no BrdlT*" 
cell was revealed in the hippocampus where the neuronal loss was prevailing. The 
failure in detecting donor cells in this region might not necessarily indicate any 
migration of grafted cells in the lesioned area, since there were unsuccessfully 
unlabelled donor cells and proliferative donor cells which might lose the BrdU-positivity 
after cell division. There was little sign of donor cell integration to the host CNS, nor 
any re-innervation of the neural network. The behavioural recovery in ischaemic mice 
having undergone ES cell-derived cell therapy may be attributable to the indirect 
therapeutic effect ES cell-derived cell product which released tropic agents into the 
damaged brain to enhance endogenous self-repair. 
- Molecular analysis revealed weak expression of transcription factor Oct-4 in ES 
cell-derived cell products. Having undergone transplantation, one out of six mice 
developed teratomas. Data suggested that pluripotent stem cells might reside in the ES 
cell-derived cell products and pose risks of teratomas formation post-transplant. 
Nonetheless, the hurdle may be over-ridden by mitomycin C treatment of ES cell-
derived cell products to inactivate proliferating cells while spare post-mitotic cells 
(Kawasaki et al. 2000). The manipulation enable the pursing of residual undifferentiated 
ES cells in the ES cell-derived cell products, which are proliferative, to evade treatment-
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related malignancy post-transplant, but at the expense of sacrificing a number of neural 
stem and progenitor cells. 
The finding of this study suggested that the employment of the SDIA of the 
neural precursor cell line CI7.2 was technically simple and efficient in the induction of 
ES cells into neural cell lineage. Neither EB formation, RA treatment nor gene 
transfection was required. The ease of performance of the process could provide a 
relatively high yield of a hierarchical population of neural cell lineage for down-
streamed studies. The approach could also offer a platform for translation to human 
se t t ing . - ‘ 
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Chapter 6 Conclusion 
ES cells are pluripotent stem cells which can differentiate into stem and 
progenitor cells of the three primary germ layers of the embryo—endoderm, mesoderm, 
and ectoderm. With the advent of biotechnology, the identification of signalling 
molecules, the discovery and application of cytokines and growth factors in cocktails of 
supra-physiologic doses, stem cell technology of in-vitro manipulation has been 
deliberately used to drive ES cells to cell lineages of interest. The derived cellular 
products have drawn and gained much attention and expectations as a novel prospective 
regimen for diseases pertaining to cell loss or degeneration, especially lived patients 
after stroke surviving with long-term to permanent neurological deficits. The approach 
of the currently available stem cell technologies for ES cell derivation is to establish an 
in-vitro condition mimicking the in-vivo stem cell niches and micro-environments of the 
cell lineages of interest. Among them, the employment of the SDIA of characterized 
lineage-related stromal cells as an inducing platform might be a feasible modality. 
In this study, the feasibility of SDIA of mouse cell lines, C17.2 cells, L cells and 
L-Wnt-3A cells, to induce and differentiate mouse ES cells, D3 and E14TG2a, into 
neural cell lineage was explored. Having been maintained and passaged in-vitro on 
PMEF in tissue culture medium supplemented with defined serum and LIF, ES cells 
were induced in non-contact co-cultures of stromal cells, expanded and selected 
sequentially in serum-free media. 
144 
Stromal cells, CI7.2 cells, L cells and L-Wnt-3A cells, were molecularly 
characterized to express neurotrophic and neutron-protective factors (BDNF, GDNF, 
CNTF, NGF, NT-3, IGF-1, IGF-2 and EPO), the angiogenic cytokine VEGF, the 
chemokine CXCL-12 and proliferative factors of bFGF and Wnt-3A. Cells with 
immuno-positivity of nestin, TuJ III, MAP-2, TH, GFAP and MBP in the ES cell-
derived cell products suggested the growth of a cell population in hierarchy of the neural 
cell lineage. Studies of the gene expression of neural cell lineage-related genes, Pax6, 
Otxl and Nurrl, indicated that there were neuro-ectodermal precursors in ES cell-
derived cell products, in addition to NSC, mature neurons, DA neurons, astrocytes and 
oligodendrocytes. Among the SDIA induced by three stromal cell lines, the outcomes 
were remarkable in both co-cultures and cultures supplemented with CM of the neural 
precursor cell line CI7.2, despite the readouts of half-diluted CM was a bit lesser. A 
proportion of 75% nestin+ colonies were achieved in the co-cultures. Apparently the 
derived cell products were relatively free from mesodermal and endodermal cells, as no 
gene expression was revealed by the RT-PCR for Brachyury and a-fetoprotein, 
"" .. respectively. Nevertheless, weak expression of the transcription factor Oct-4 was noted 
alerting the likely residues of undifferentiated ES cells in the derived cell products. 
In-vivo studies of the SDIA-induced cell products demonstrated a significant 
recovery of spatial learning and memory ability in ischaemic mice post-transplant as 
compared to ischaemic mice receiving sham operation. The spatial learning and 
memory ability of transplanted mice and normal control mice were comparable. The 
cell tracking of transplanted ES cell-derived cell products demonstrated BrdU-labelled 
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cells localized along the needle track of injection in the brain. The migration of BrdlJ^ 
cells was evident in the vicinity and few BrdlJ+ cells were also revealed in brain tissues 
contra-lateral to the site of injection. The clinical relevance of ES cell-derived cell 
products induced by the SDIA of the mouse neural precursor cell line CI 7.2 was notable 
in this study. However, the precise mechanisms underlying the clinical relevance were 
not elucidated. Besides, teratoma was noted in one of the transplanted animals. 
Data of this study suggested that a hierarchical population of neural cell lineage 
could be in-vitro derived from ES cells through the SDIA of neural precursor cell line 
CI 7.2 and the clinical relevance was evident in a mouse model of brain ischaemia. The 
method, which was basically developed to mimic the microenvironment of the CNS, is 
technically simple and efficient. Nether EB formation, RA treatment nor gene 
transfection is requisite. However, there is still room for improvement to over-ride the 
hurdle of teratoma post-transplant. The finding of this study may provide a platform to 
study the SDIA of human stromal cells in the derivation of human ES cells and translate 
. subsequently to cellular therapy for patients having attacked by ischaemic stroke. 
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